<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001892.pub2" GROUP_ID="RENAL" ID="741499082409262888" MERGED_FROM="" MODIFIED="2009-05-12 01:50:03 +0200" MODIFIED_BY="Narelle Willis" REVIEW_NO="001" REVMAN_SUB_VERSION="5.0.20" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="12.2">
<COVER_SHEET MODIFIED="2009-05-12 01:50:03 +0200" MODIFIED_BY="Narelle Willis">
<TITLE>Low protein diets for chronic kidney disease in non diabetic adults</TITLE>
<CONTACT MODIFIED="2009-05-12 01:50:03 +0200" MODIFIED_BY="Narelle Willis"><PERSON ID="16102" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Denis</FIRST_NAME><LAST_NAME>Fouque</LAST_NAME><EMAIL_1>denis.fouque@chu-lyon.fr</EMAIL_1><ADDRESS><DEPARTMENT>Département de Néphrologie</DEPARTMENT><ORGANISATION>U870 INSERM-Université Claude Bernard Lyon 11</ORGANISATION><ADDRESS_1>Hôpital Edouard Herriot</ADDRESS_1><CITY>Lyon Cedex 03</CITY><ZIP>69437</ZIP><COUNTRY CODE="FR">France</COUNTRY><PHONE_1>+33 4 72110202</PHONE_1><FAX_1>+33 4 72110203</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2009-05-12 01:50:03 +0200" MODIFIED_BY="Narelle Willis"><PERSON ID="16102" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Denis</FIRST_NAME><LAST_NAME>Fouque</LAST_NAME><EMAIL_1>denis.fouque@chu-lyon.fr</EMAIL_1><ADDRESS><DEPARTMENT>Département de Néphrologie</DEPARTMENT><ORGANISATION>U870 INSERM-Université Claude Bernard Lyon 11</ORGANISATION><ADDRESS_1>Hôpital Edouard Herriot</ADDRESS_1><CITY>Lyon Cedex 03</CITY><ZIP>69437</ZIP><COUNTRY CODE="FR">France</COUNTRY><PHONE_1>+33 4 72110202</PHONE_1><FAX_1>+33 4 72110203</FAX_1></ADDRESS></PERSON><PERSON ID="16119" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Maurice</FIRST_NAME><LAST_NAME>Laville</LAST_NAME><POSITION>Head</POSITION><EMAIL_1>maurice.laville@chu-lyon.fr</EMAIL_1><ADDRESS><DEPARTMENT>Service de Néphrologie</DEPARTMENT><ORGANISATION>Hôpital Edouard Herriot</ORGANISATION><CITY>Lyon Cedex 03</CITY><ZIP>69437</ZIP><COUNTRY CODE="FR">France</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2009-04-21 08:38:32 +1000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="31" MONTH="3" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="3" YEAR="2009"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="11" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2009-05-12 09:43:30 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2009-05-12 09:43:30 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>Author list updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-04-22 11:51:23 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="3" YEAR="2009"/>
<DESCRIPTION>
<P>Two new studies added, no change to conclusions</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-03-31 15:40:10 +1100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-03-31 15:40:10 +1100" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="30" MONTH="11" YEAR="2005"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Hospices Civils de Lyon</NAME>
<COUNTRY CODE="FR">France</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University Claude Bernard Lyon 1</NAME>
<COUNTRY CODE="FR">France</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-05-12 09:35:11 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2009-04-21 08:49:54 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-10-14 10:48:39 +1100" MODIFIED_BY="[Empty name]">Low protein diets can delay kidney failure in people with kidney disease (diabetic kidney disease excluded)</TITLE>
<SUMMARY_BODY MODIFIED="2009-04-21 08:49:54 +1000" MODIFIED_BY="[Empty name]">
<P>Kidney disease (nephropathy) can lead to kidney failure (end-stage kidney disease). A diet low in protein is sometimes recommended to try to slow the progression of kidney disease. Monitoring compliance with a protein-restricted diet is possible by determining urea production since urea is a byproduct of the degradation of all proteins. If urea production is reduced then the accumulation of toxins will be limited.The review of studies for people with kidney disease (diabetic kidney disease excluded) found that low protein diets can delay end-stage kidney disease.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-04-23 10:24:21 +1000" MODIFIED_BY="Narelle S Willis">
<ABS_BACKGROUND MODIFIED="2009-04-21 08:49:05 +1000" MODIFIED_BY="[Empty name]">
<P>For more than fifty years, low protein diets have been proposed to patients with kidney failure. However, the effects of these diets in preventing severe kidney failure and the need for maintenance dialysis have not been resolved.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To determine the efficacy of low protein diets in delaying the need to start maintenance dialysis.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-04-21 08:45:58 +1000" MODIFIED_BY="[Empty name]">
<P>Cochrane Renal Group studies register, the Cochrane Central Register of Controlled studies, MEDLINE, and EMBASE. Congress abstracts (American Society of Nephrology since 1990, European Dialysis Transplant Association since 1985, International Society of Nephrology since 1987). Direct contacts with investigators.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2009-04-21 08:49:23 +1000" MODIFIED_BY="[Empty name]">
<P>Randomised studies comparing two different levels of protein intake in adult patients suffering from moderate to severe kidney failure, followed for at least one year.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-04-21 08:46:32 +1000" MODIFIED_BY="[Empty name]">
<P>Two authors independently selected studies and extracted data. Statistical analyses were performed using the random effects model and the results expressed as risk ratio (RR) for dichotomous outcomes with 95% confidence intervals (CI). Collection of the number of "renal deaths" defined as the need for starting dialysis, the death of a patient or a kidney transplant during the study.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-04-23 10:24:21 +1000" MODIFIED_BY="Narelle S Willis">
<P>Ten studies were identified from over 40 studies. A total of 2000 patients were analysed, 1002 had received reduced protein intake and 998 a higher protein intake. There were 281 renal deaths recorded, 113 in the low protein diet and 168 in the higher protein diet group (RR 0.68, 95% CI 0.55 to 0.84, P = 0.0002). To avoid one renal death, 2 to 56 patients need to be treated with a low protein diet during one year.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-04-08 09:49:29 +1000" MODIFIED_BY="Narelle S Willis">
<P>Reducing protein intake in patients with chronic kidney disease reduces the occurrence of renal death by 32% as compared with higher or unrestricted protein intake. The optimal level of protein intake cannot be confirmed from these studies.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-04-23 10:25:21 +1000" MODIFIED_BY="Narelle S Willis">
<BACKGROUND MODIFIED="2009-04-21 08:54:58 +1000" MODIFIED_BY="[Empty name]">
<P>During the past years, numerous experimental and clinical studies have addressed the question of reducing protein intake to retard or even halt the development of non-specific glomerular or interstitial lesions, and hence the progression of patients towards end-stage kidney disease (ESKD). Despite the large number of studies on dietary interventions that were performed a few decades ago, it is still unclear if patients should limit their protein intake and if so, to what extent nutritional behaviour should be changed during chronic kidney disease (CKD). Most of the clinical studies were designed to test the efficacy of reducing protein intake on surrogate renal function outcomes, such as serum creatinine increase or creatinine clearance decrease over time. Unfortunately, changing protein intake will modify all creatinine markers and therefore no valid conclusions can be drawn from these studies. Reducing protein intake decreases creatinine production, reduces renal function (glomerular filtration as well as creatinine clearance) by unidentified mechanisms. Although a few studies used what are considered as gold standard renal function assessments such as glomerular filtration rate (GFR) the results from these studies have been conflicting. Moreover, GFR is not a clinical outcome.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-11-26 10:39:40 +1100" MODIFIED_BY="Narelle S Willis">
<P>To determine the efficacy of low protein diets in preventing the natural progression of CKD towards ESKD and retard the need for starting maintenance dialysis.</P>
</OBJECTIVES>
<METHODS MODIFIED="2009-04-21 08:50:55 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2009-04-21 08:45:54 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2009-04-21 08:45:49 +1000" MODIFIED_BY="[Empty name]">
<P>Studies in which participants have been randomly allocated to receive either their usual intake of protein or were asked to limit their protein intake for at least 12 months. Cross-over studies were considered if the starting period of intervention was randomly allocated.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2009-04-21 08:45:54 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>All patients suffering from moderate to severe CKD, as estimated by either serum creatinine, creatinine clearance or GFR measurement.</LI>
<LI>Because of difficulty to control for confounding factors, studies including diabetic patients or children with CKD were excluded from analysis.</LI>
</UL>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Standard protein intake (0.8 g/kg/d) or greater versus a moderate (0.6 g/kg/d) to severe protein restriction (0.3 g/kg/d) regardless of supplementation with essential amino acids or ketoacids.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-10-14 11:00:43 +1100" MODIFIED_BY="[Empty name]">
<P>Renal death as defined by:</P>
<OL>
<LI>Death during follow-up, due to any cause</LI>
<LI>Need to start haemodialysis or peritoneal dialysis during follow-up</LI>
<LI>Kidney transplant during the study</LI>
</OL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-04-21 08:45:55 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Initial search</HEADING>
<P>The initial search for studies was performed by one of the authors (DF) using the Cochrane Renal Group search strategy. The Renal Group studies Register was searched by Sandrine Dury, studies Search Coordinator. MEDLINE and EMBASE were searched from January 1966 through to June 1999. (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> - <I>Electronic search strategies).</I>
</P>
<P>Congress abstracts (American Society of Nephrology since 1990, European Dialysis Transplant Association since 1985, International Society of Nephrology since 1987) were handsearched. Authors of published work were contacted to ask if they were aware of any unpublished studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Review update</HEADING>
<P>For review updates the Cochrane Renal Group's specialised register and The Cochrane Central Register of Controlled studies (CENTRAL, in <I>The Cochrane Library</I>) was searched. CENTRAL and the Renal Group's specialised register contain the handsearched results of conference proceedings from general and speciality meetings. This is an ongoing activity across the Cochrane Collaboration and is both retrospective and prospective <A HREF="http://(http://www.cochrane.us/masterlist.asp">(http://www.cochrane.us/masterlist.asp</A>). Please refer to The Cochrane Renal Review Group's Module in <I>The Cochrane Library</I> for the complete lis of nephrology conference proceedings searched.</P>
</SUBSECTION>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-04-21 08:50:55 +1000" MODIFIED_BY="[Empty name]">
<P>Two authors independently selected studies for inclusion in the review. Disagreements were resolved by discussion. For each study, the number of patients originally allocated to each treatment group was noted and an intention-to-treat analysis was performed. Data were obtained directly from investigators when not available in the published report.</P>
<P>Data collected for each study included inclusion and exclusion criteria, patient details (age, gender), type of diet prescribed (level of proposed protein intake, nature of proteins, supplementation in energy or amino-acids), time to the start of dialysis if available. The nature of kidney disease was recorded to verify that the distribution of prognostic factors was balanced between the groups.</P>
<P>No quality assessment of the studies was performed. Details of the randomisation processes were obtained directly from the investigators.</P>
<P>Heterogeneity was analysed using a chi-squared test on N-1 degrees of freedom, with an alpha of 0.05 used for statistical significance and with the I² test (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). I² values of 25%, 50% and 75% correspond to low, medium and high levels of heterogeneity.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-04-23 10:25:21 +1000" MODIFIED_BY="Narelle S Willis">
<STUDY_DESCRIPTION MODIFIED="2009-04-21 08:55:27 +1000" MODIFIED_BY="[Empty name]">
<P>Ten RCTs were identified and retained for this review, with 2000 patients, 1002 in the restricted protein intake groups and 998 in the unrestricted or higher protein intake groups. The number of patients in each study varied from 19 (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>) to 585 (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>). The collection of events was done after the longest observation time obtained in each study. Data obtained during follow-up but after completion of studies, if present, were not considered for analysis.</P>
<P>Randomisation and allocation concealment was done using a computer and kept concealed using numbered, opaque sealed envelopes (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>), envelopes after stratification by age, gender and renal function (<LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK>), after stratification by renal function and blood pressure levels, by centre and study and by block permutation (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>), after allocating envelopes without stratification (<LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>; <LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>; <LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>), by random number table and a telephone call (<LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK>), random number table (<LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK>). The method of randomisation was not stated in <LINK REF="STD-di-Iorio-2003" TYPE="STUDY">di Iorio 2003</LINK> and <LINK REF="STD-Mirescu-2007" TYPE="STUDY">Mirescu 2007</LINK>.</P>
<P>The level of renal insufficiency as assessed by CKD stage was moderate (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK> study 1 (CKD 3-4); <LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK> (CKD 3-4), <LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK> study A1-B (CKD 3)) or severe (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK> (CKD 4-5); <LINK REF="STD-di-Iorio-2003" TYPE="STUDY">di Iorio 2003</LINK> (CKD 4-5); <LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK> (CKD 4-5); <LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK> (CKD 5); <LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK> study 2 (CKD 4); <LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK> (CKD 4-5); <LINK REF="STD-Mirescu-2007" TYPE="STUDY">Mirescu 2007</LINK> (CKD 4); <LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK> study A2-C (CKD 4-5) and <LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK> (CKD 4-5).</P>
<P>Mean age of patients was: 48 years (range 15-73) (<LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK>), 62 (32-79) (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>), 49 (18-65) (<LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK>), 55 (15-75) (<LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK>), 44 (15-70) (<LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>), 61 (± 18) (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>), 52 (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>) and 55 (<LINK REF="STD-di-Iorio-2003" TYPE="STUDY">di Iorio 2003</LINK>; <LINK REF="STD-Mirescu-2007" TYPE="STUDY">Mirescu 2007</LINK>).</P>
<P>The type of kidney disease was available for all studies. Glomerulopathies represented 36% of included patients (<LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK>), 26% (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>), 29% (<LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK>), 28% (<LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK>), 47% (<LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>), 23% (<LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>), 25% (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>); 58% (<LINK REF="STD-Mirescu-2007" TYPE="STUDY">Mirescu 2007</LINK>)' 35% (<LINK REF="STD-di-Iorio-2003" TYPE="STUDY">di Iorio 2003</LINK>) and 24% (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>). Polycystic kidney disease was present in 6% of patients (<LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK>), 21% (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>), 16% (<LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK>), 30% (<LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK>), 18% (<LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>), 17% (<LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>), 24% (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>) and 8% (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>). Interstitial nephritis was present in 24% of patients (<LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK>), 16% (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>), 34% (<LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK>), 14% (<LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK>), 26% (<LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>), 17% (<LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>), 15% (<LINK REF="STD-di-Iorio-2003" TYPE="STUDY">di Iorio 2003</LINK>), 28% (<LINK REF="STD-Mirescu-2007" TYPE="STUDY">Mirescu 2007</LINK>), 26% (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>) and was not reported (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>). Importantly, these nephropathies were equally distributed between groups within studies. Six diabetic nephropathy patients were included in <LINK REF="STD-di-Iorio-2003" TYPE="STUDY">di Iorio 2003</LINK> (30%). There were three patients in each group.</P>
<P>Gender (M/F) was as follows: 0.56 (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>), 0.54 (<LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK>), 0.37 (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>), 0.54 (<LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK>), 0.58 (<LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK>), 0.67 (<LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>), 0.63 (<LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>), 0.61 (<LINK REF="STD-Mirescu-2007" TYPE="STUDY">Mirescu 2007</LINK>) and 0.60 (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>; <LINK REF="STD-di-Iorio-2003" TYPE="STUDY">di Iorio 2003</LINK>), reflecting the higher male prevalence of kidney disease. Again, no difference between treated and control groups was observed.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>There was no follow-up of treatment, because of the nature of the nutritional intervention. All studies appeared to use adequate randomisation processes. </P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-04-23 10:25:21 +1000" MODIFIED_BY="Narelle S Willis">
<SUBSECTION>
<HEADING LEVEL="3">Low protein diets versus free or higher protein diets</HEADING>
<P>The overall unadjusted incidence of renal death in the control groups was 17%, and ranged from 6% (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>) to 78% (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>). All but one study (<LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>) showed a trend for a beneficial effect of a restricted protein intake compared with an unrestricted intake, and one study showed a statistically significant difference (<LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>). There was no heterogeneity between studies (&#967;² = 8.20, df = 9, P = 0.51; I² = 0%). The overall effect was found to be highly significant, with 113 renal deaths observed with restricted protein intake compared with 168 events in the unrestricted protein intake (RR 0.68, 95% CI 0.55 to 0.84). There was a 32% relative risk reduction in renal death (P = 0.0002) in favour of a restricted protein intake. Of importance, due to randomisation, there was a similar percentage in categories of kidney disease (glomerulopathy, interstitial nephritis, nephroangiosclerosis, polycystic disease) in both restricted and unrestricted protein intake groups.</P>
<P>The number of patients needed to be treated (NNT) during one year to avoid one renal death ranged from 2 (<LINK REF="STD-di-Iorio-2003" TYPE="STUDY">di Iorio 2003</LINK>), 4 (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>), 5 (<LINK REF="STD-Mirescu-2007" TYPE="STUDY">Mirescu 2007</LINK>) 8 (<LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK>), 11 (<LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>), 11 (<LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>), 14 (<LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK>), 37 (<LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK>), 50 (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>) and 56 (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>). To estimate the overall benefit of a restricted protein intake longer than one year, these results should be divided by the number of years during which the low protein diet is prescribed.</P>
<P>There was some heterogeneity between diets. This reflects the absence of homogenous experimental hypotheses and the historical background of these treatments. Theoretically, the mean difference in protein intake between higher and restricted protein intake groups was approximately 0.35 g/kg/d in all studies except 0.2 g/kg/d (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>; <LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>) and 0.7 g/kg/d (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>). However, based on urinary collection of protein waste products, the actual reduction in protein intake between groups in each study was less than expected and close to 0.2 g/kg/d (<LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK>), 0.25 g/kg/d (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>; <LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>; <LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>), 0.3 g/kg/d (<LINK REF="STD-Mirescu-2007" TYPE="STUDY">Mirescu 2007</LINK>; <LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK>) and 0.35 g/kg/d (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>, in (<LINK REF="REF-Kopple-1997" TYPE="REFERENCE">Kopple 1997</LINK>)). This value should be considered to be the true therapeutic intervention estimated by the present review.</P>
<P>The sub-analysis (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>.1) according to a more liberal intake (0.6 g/kg/d versus higher protein intake, three studies) showed little effect on renal death (RR 0.76, 95% CI 0.54 to 1.05, P = 0.10) whereas for the analysis of more reduced protein intakes (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>.2, 0.3 to 0.6 g/kg/d versus higher/free protein intake, 7 studies), the difference in renal deaths was strongly significant (RR 0.63, 95% CI 0.48 to 0.83, P = 0.0009).</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2009-04-21 08:56:22 +1000" MODIFIED_BY="[Empty name]">
<P>Updating two previous meta-analyses (<LINK REF="REF-Fouque-1992" TYPE="REFERENCE">Fouque 1992</LINK>; <LINK REF="REF-Pedrini-1996" TYPE="REFERENCE">Pedrini 1996</LINK>), this review shows that reducing the protein intake of patients with CKD significantly reduces the number of patients entering ESKD by about 32% (P = 0.0002).</P>
<P>For many decades, reducing protein intake has been proposed for patients suffering from kidney disease for metabolic purposes. Urea production, and hence, serum urea can be reduced by a low protein diet. More recently experimental studies have suggested that a low protein intake may prevent the natural progression of CKD towards ESKD thus delaying the start of maintenance dialysis treatment (<LINK REF="REF-Klahr-1989" TYPE="REFERENCE">Klahr 1989</LINK>). Reducing protein intake modifies creatinine concentration, and since this was used as an intermediary outcome in many reports published since 1975, it is not possible to use these data to reliably assess the effects of low protein diets. To avoid problems raised by the use of intermediary outcomes, we chose a robust clinical end-point, renal death. This end-point was easily observed for all patients, i.e., the date of first dialysis session, kidney transplant or the death of a patient during the study. Since in some studies, patients were transplanted before starting dialysis, we also counted them as renal death. These results were obtained accurately from each paper or by direct contact with the investigators.</P>
<P>A number of comments should be made (<LINK REF="REF-Sacks-1987" TYPE="REFERENCE">Sacks 1987</LINK>; <LINK REF="REF-Boissel-1989" TYPE="REFERENCE">Boissel 1989</LINK>). First, although the populations studied were clinically heterogeneous in age, gender, types of nephropathy and the level of protein restriction, the effects of treatments were not statistically different (heterogeneity test, P = 0.51; I² = 0%). Secondly, although the protein intakes were quite different between studies, the fact that a common effect was found indicates that the gradient in protein intake is the therapeutic factor. In fact, due to a well described spontaneous increase in protein intake during a diet (<LINK REF="REF-Kopple-2000" TYPE="REFERENCE">Kopple 2000</LINK>), it was not surprising that the true protein intake gradient between groups was less than expected. Thus, the effect of the diet might have been even more pronounced if the diet was better adhered to. Thirdly, because the decision to start dialysis is often based on serum urea levels (but not only), and since low protein diets decrease these urea levels, it can be expected that patients with a reduced protein intake will have a more reduced serum urea levels and, hence, will start dialysis later than patients with higher protein intake. Only studies measuring GFR and reporting a decrease in renal function over time may give this information. In the present report, two studies used these markers: (<LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>) showed a beneficial effect and (<LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>) reported a nearly significant beneficial effect (P = 0.07). Interestingly, <LINK REF="REF-Kasiske-1998" TYPE="REFERENCE">Kasiske 1998</LINK> performed a meta-analysis on the renal function deterioration (not on the renal death) and showed a moderate but significant protection by low protein diets (0.5 mL/min/y less loss for restricted protein intakes than for higher protein intakes). Even if this represents a renal protective effect of low protein diets, it is moderate and not responsible for the greater reduction in renal death we have observed in the present review. Thus, it is probably a combination of renal protection and better metabolic control offered by the low protein diets that may explain the benefit we report here.</P>
<P>The NNT is a tool recently introduced to better compare the strength of a treatment between studies and to homogenise these effects when absolute even risks are quite different between studies (<LINK REF="REF-Altman-1999" TYPE="REFERENCE">Altman 1999</LINK>). In the present review, NNT during one year for each study varied from 2 to 56. These variations mainly depend on the basal risk for renal death at inclusion and correspond to the impairment in renal function, since the absolute risk of renal death during the study is greater when renal function is more impaired (<LINK REF="STD-Jungers-1987" TYPE="STUDY">Jungers 1987</LINK>; <LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK>). However, the amplitude of NNTs among studies is not very large (2 to 56) and thus appears to be very acceptable in primo-secondary prevention for a treatment that is not expensive and whose potential side-effects can be avoided by routine dietary survey. Moreover, these results compare favourably with the well-accepted mortality reduction obtained by prescribing statins in the 4S study (NNT = 30) or in the WOSCOPS study (NNT = 111) (<LINK REF="REF-Skolbekken-1998" TYPE="REFERENCE">Skolbekken 1998</LINK>).</P>
<P>The funnel plot represents the individual risk ratio (RR) corresponding to the study patients number (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). The funnel plot representation (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>) shows that the RR from the four largest studies (<LINK REF="STD-Cianciaruso-2008" TYPE="STUDY">Cianciaruso 2008</LINK>; <LINK REF="STD-Locatelli-1991" TYPE="STUDY">Locatelli 1991</LINK>; <LINK REF="STD-MDRD-1994" TYPE="STUDY">MDRD 1994</LINK>; <LINK REF="STD-Rosman-1989" TYPE="STUDY">Rosman 1989</LINK>) are closer to the common RR (i.e. 0.68), whereas the smaller studies (<LINK REF="STD-Ihle-1989" TYPE="STUDY">Ihle 1989</LINK>; <LINK REF="STD-Malvy-1999" TYPE="STUDY">Malvy 1999</LINK>; <LINK REF="STD-Mirescu-2007" TYPE="STUDY">Mirescu 2007</LINK>) provide smaller RRs (0.14 to 0.34), suggesting a stronger beneficial effect of reducing protein intake. The fact that only one small size study provided an RR greater than 0.61 (<LINK REF="STD-Williams-1991" TYPE="STUDY">Williams 1991</LINK>) suggests that a publication bias might have occurred. Indeed, if investigators found negative or less robust conclusions on small effects (e.g. 20 to 100 patients), they might have censored themselves and were reluctant to report their findings. Also, medical journals might have refused to publish negative studies due to inadequate size.</P>
<P>Although the sub-analysis based on the degree of protein restriction led to a stronger benefit for more restricted protein intake, there are some nutritional risks to a more restricted protein intake in CKD patients. In this review, sparse nutritional data could not allow a reliable assessment of nutritional consequences of such diets. Thus, a combined analysis of survival data in one hand and nutritional requirements in another hand should recommend a protein intake closer to 0.6 rather than 0.3 g/kg/d.</P>
<P>Attention should be focused on the potential additive protective effect of a reduction in protein intake and the renoprotective drugs ACE inhibitors as reported by <LINK REF="REF-Gansevoort-1995" TYPE="REFERENCE">Gansevoort 1995</LINK>.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-04-21 08:53:21 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2009-04-21 08:53:21 +1000" MODIFIED_BY="[Empty name]">
<P>A nutritional intervention should be proposed to patients with moderate CRF, including a reduction in protein intake. The optimal level of protein intake cannot be deduced from the present review. The fact that the actual patient protein intake was greater than prescribed in all studies suggests that a skilled and regular dietary survey should be proposed (NKF-KDOQI Guideline #23, in (<LINK REF="REF-DOQI-2000" TYPE="REFERENCE">DOQI 2000</LINK>)). Moreover, it has been demonstrated that patients with CRF left without dietetic survey will express a progressive decline in protein and energy intakes, potentially contributing to the decline in nutritional markers (<LINK REF="REF-Kopple-2000" TYPE="REFERENCE">Kopple 2000</LINK>). By contrast, feasibility of low protein diets has been shown in large studies with convincing results (<LINK REF="REF-Aparicio-2000" TYPE="REFERENCE">Aparicio 2000</LINK>), highlighting the fact that interested teams can motivate patients to the point of excellent compliance and optimal nutritional benefit, a goal that should be reached for most patients in all renal units. Thus, based on physician enthusiasm and dietary survey, the patient may eventually make his personal treatment choice. Factors other than diet therapy have demonstrated a renal protective effect and have been shown to be able to delay ESKD (<LINK REF="REF-Locatelli-1999" TYPE="REFERENCE">Locatelli 1999</LINK>). These include angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, blood pressure control, optimal glucose monitoring in diabetic patients. Even if it is more difficult to modify dietary habits than taking blood pressure treatment, a restricted protein intake should be proposed to the patients in addition to other current and future renoprotective treatments.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Further nutritional studies may be necessary to characterise the optimal level of protein restriction and duration of intervention. Additional studies should test a potential additive effect of a low protein diet in combination with angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists or other antiproteinuric medications.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2009-05-12 09:35:11 +1000" MODIFIED_BY="[Empty name]">
<P>We are grateful to Prof Jean-Pierre Boissel who contributed to the original iteration of this review (<LINK REF="REF-Fouque-2000b" TYPE="REFERENCE">Fouque 2000b</LINK>; <LINK REF="REF-Fouque-2006" TYPE="REFERENCE">Fouque 2006</LINK>), contributing to the design, quality assessment, data collection, entry, analysis and interpretation, and writing.</P>
<P>We thank the authors of each included study for providing additional data and are particularly indebted to Michel Cucherat MD PhD, Margaret Haugh PhD and the Centre Cochrane Français for statistical and methodological assistance. Prof Bert Kasiske and Prof Teut Risler should be acknowledged for critically reviewing the manuscript.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-04-23 10:51:20 +1000" MODIFIED_BY="Narelle S Willis">
<P>Prof Denis Fouque has received lecture fees for the topic "Nutrition and progression of chronic kidney disease".<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-04-21 08:59:02 +1000" MODIFIED_BY="[Empty name]">
<P>DF and JPB independently selected studies for inclusion in the review.<BR/>All authors contributed to the data analysis and writing of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-04-21 08:57:01 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2009-04-08 10:32:55 +1000" MODIFIED_BY="Narelle S Willis">
<INCLUDED_STUDIES MODIFIED="2008-11-26 15:17:14 +1100" MODIFIED_BY="Narelle S Willis">
<STUDY DATA_SOURCE="PUB" ID="STD-Cianciaruso-2008" MODIFIED="2008-11-26 13:56:31 +1100" MODIFIED_BY="Narelle S Willis" NAME="Cianciaruso 2008" YEAR="2008">
<REFERENCE MODIFIED="2008-11-24 15:44:04 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cianciaruso B, Pota A, Pisani A, Torraca S, Annecchini R, Lombardi P et al</AU>
<TI>Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>2</NO>
<PG>636-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 13:56:31 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Cianciaruso B, Pota A, Torraca S, Somma G, Nazzaro P, Annecchini R et al</AU>
<TI>Comparison of two different protein intakes (0.3-0.6 vs 0.7-0.9 g/kg/day) on the metabolic control of advanced renal failure [abstract]</TI>
<SO>ERA - EDTA Congress; 2004; May 15-18; Lisbon (Portugal)</SO>
<YR>2004</YR>
<PG>295</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-di-Iorio-2003" NAME="di Iorio 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Di Iorio BR, Minutolo R, De Nicola L, Bellizzi V, Catapano F, Iodice C et al</AU>
<TI>Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure</TI>
<SO>Kidney International</SO>
<YR>2003</YR>
<VL>64</VL>
<NO>5</NO>
<PG>1822-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="14717953"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ihle-1989" NAME="Ihle 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Ihle BU, Becker G, Whithworth JA, Charlwood RA, Kincaid-Smith PS. The effect of protein restriction on the progression of renl insufficiency. N Engl J Med 1989;321:1773-1777.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ihle BU, Becker G, Whithworth JA, Charlwood RA, Kincaid-Smith PS</AU>
<TI>The effect of protein restriction on the progression of renal insufficiency</TI>
<SO>New England Journal of Medicine</SO>
<YR>1989</YR>
<VL>321</VL>
<NO>26</NO>
<PG>1773-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2512486"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jungers-1987" NAME="Jungers 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Jungers P, Chauveau P, Ployard F, Lebkiri B, Ciancioni C, Man NK. Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney Int 1987;22:67-71&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jungers P, Chauveau P, Ployard F, Lebkiri B, Ciancioni C, Man NK</AU>
<TI>Comparison of ketoacids and low protein diet on advanced chronic renal failure progression</TI>
<SO>Kidney International - Supplement</SO>
<YR>1987</YR>
<VL>22</VL>
<PG>67-71</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3323621"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Locatelli-1991" MODIFIED="2008-11-26 15:17:14 +1100" MODIFIED_BY="Narelle S Willis" NAME="Locatelli 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-11-26 15:17:14 +1100" MODIFIED_BY="Narelle S Willis" NOTES="&lt;p&gt;Locatelli F, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A, et al. Prospective, randomised, multicentre trial of effect of protein restriction on the progression of renal insufficiency. Lancet 1991;337:1299-1304.&lt;/p&gt;" NOTES_MODIFIED="2008-11-26 15:17:14 +1100" NOTES_MODIFIED_BY="Narelle S Willis" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Locatelli F, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A</AU>
<TI>Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>337</VL>
<NO>8753</NO>
<PG>1299-304</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1674294"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 15:16:57 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tentori F, Marai P, Marcelli D, Ponti R, La Milla V, Locatelli F</AU>
<TI>Monocentric prospective randomised controlled study on the progression rate of chronic renal failure with two different protein intakes [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1987</YR>
<VL>2</VL>
<NO>5</NO>
<PG>400</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malvy-1999" MODIFIED="2008-10-14 10:54:09 +1100" MODIFIED_BY="[Empty name]" NAME="Malvy 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malvy D, Maingourd C,Pengloan J, Bagros P,Nivet H</AU>
<TI>Effects of severe protein restriction with ketoanalogues in advanced renal failure</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>1999</YR>
<VL>18</VL>
<NO>5</NO>
<PG>481-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10511331"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:54:09 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nivet H, Maingourd C, Malvy D, Pengloan J, Bagros PH</AU>
<TI>Effects of severe protein-restriction with ketoanalogues in advanced renal failure [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1992</YR>
<VL>3</VL>
<NO>3</NO>
<PG>286</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:54:09 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:54:09 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00461412"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MDRD-1994" MODIFIED="2008-10-14 10:55:10 +1100" MODIFIED_BY="[Empty name]" NAME="MDRD 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994;330:877-884.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW et al</AU>
<TI>The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group</TI>
<SO>New England Journal of Medicine</SO>
<YR>1994</YR>
<VL>330</VL>
<NO>13</NO>
<PG>877-84</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="8114857"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:54:16 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MDRD Study Group, Hunsicker LG, Adler S, Caggiula AW, England B, Greene T et al</AU>
<TI>Relationship among baseline proteinuria (p), mean arterial blood pressure (map) during follow-up, and decline in glomerular filtration rate (agfr) in the modification of diet in renal disease study [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1993</YR>
<VL>4</VL>
<NO>Program &amp; Abstracts</NO>
<PG>254</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:54:16 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:54:16 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00485053"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:54:24 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MDRD Study Group, Kusek JW, Agodoa L, Greene T, Jones C</AU>
<TI>Comparison of decline of gfr in blacks versus non-blacks in the mdrd study [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1993</YR>
<VL>4</VL>
<NO>Program &amp; Abstracts</NO>
<PG>253</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:54:24 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:54:24 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00485054"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:54:29 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MDRD Study Group, Levey AS, Beck GJ, Caggiula AW, Greene T, Hunsicker LG et al</AU>
<TI>A hypothesis for the results of the modification of diet in renal disease (mdrd) study. [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1993</YR>
<VL>4</VL>
<NO>Program &amp; Abstracts</NO>
<PG>253</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:54:29 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:54:29 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00485055"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:54:34 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MDRD Study Group, Levey AS, Bosch JP, Coggins CH, Greene T, Mitch WE et al</AU>
<TI>Effects of diet and blood pressure on creatinine clearance (ccr) and serum creatinine (pcr) in the mdrd study. [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1993</YR>
<VL>4</VL>
<NO>Program &amp; Abstracts</NO>
<PG>253</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:54:34 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:54:34 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00485056"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:54:39 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MDRD Study Group, Peterson JC, Burkart J, Greene T, Hebert L, King A et al</AU>
<TI>The effect of blood pressure control on progression of renal disease depends on level of proteinuria (p) at baseline evaluation [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1993</YR>
<VL>4</VL>
<NO>Program &amp; Abstracts</NO>
<PG>254</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:54:39 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:54:39 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00485057"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:54:44 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MDRD Study Group, Porush JG, Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T et al</AU>
<TI>Efficacy of anti-hypertensive interventions in reducing blood pressure in the mdrd study [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1995</YR>
<VL>6</VL>
<NO>3</NO>
<PG>400</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:54:44 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:54:44 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00485058"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:54:52 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MDRD Study Group, Rocco MV, Coyne T, Eastin S, Faubert J, Gassman JJ et al</AU>
<TI>Patient symptoms and quality of life in the mdrd study at enrollment-correlation with gfr [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1993</YR>
<VL>4</VL>
<NO>Program &amp; Abstracts</NO>
<PG>254</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:54:52 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:54:52 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00485060"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:54:59 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MDRD Study Group, prepared by Levey AS, Beck GJ, Bosch JP, Caggiula AW, Greene T et al</AU>
<TI>Short-term effects of protein intake, blood pressure, and antihypertensive therapy on gfr in the mdrd study. [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1995</YR>
<VL>6</VL>
<NO>3</NO>
<PG>395</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:54:59 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:54:59 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00487729"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:55:10 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yamamoto ME, Olson MB, Stollar C, MDRD Study Group</AU>
<TI>Effects of weight and na+ change on blood pressures of hypertensive mdrd study patients [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1995</YR>
<VL>6</VL>
<NO>3</NO>
<PG>408</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:55:10 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:55:10 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00486522"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mirescu-2007" MODIFIED="2008-11-24 15:38:28 +1100" MODIFIED_BY="[Empty name]" NAME="Mirescu 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-11-24 15:38:28 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mircescu G, Garneata L, Stancu SH, Capusa C</AU>
<TI>Effects of a supplemented hypoproteic diet in chronic kidney disease</TI>
<SO>Journal of Renal Nutrition</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>3</NO>
<PG>179-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rosman-1989" MODIFIED="2008-11-26 14:11:37 +1100" MODIFIED_BY="Narelle S Willis" NAME="Rosman 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-11-26 13:58:02 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Donker AJ, Piers-Becht TP</AU>
<TI>Four-years Follow-up of Patients with Chronic Renal Insufficiency Randomly allocated to a Protein-restricted Diet and a Control Group [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1989</YR>
<VL>4</VL>
<NO>5</NO>
<PG>455</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 13:58:02 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Donker AJ, Rosman JB, Piers-Becht TP, Sluiter WJ</AU>
<TI>Effect of protein restriction in chronic renal insufficiency: a prospective randomized trial [abstract]</TI>
<SO>Kidney International</SO>
<YR>1985</YR>
<VL>27</VL>
<PG>137</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-10-14 10:55:18 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosman JB, Donker AJ, Meijer S, Sluiter WJ, Piers-Becht TP, van der Hem GK</AU>
<TI>Two years' experience with protein restriction in chronic renal failure</TI>
<SO>Contributions to Nephrology</SO>
<YR>1986</YR>
<VL>53</VL>
<PG>109-20</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:55:18 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:55:18 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00420852"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 14:11:06 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosman JB, Donker AJ</AU>
<TI>The Response to a Low-protein Diet to Retard the Progression of Renal Failure is Sex-Dependent [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1989</YR>
<VL>4</VL>
<NO>5</NO>
<PG>457</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 13:58:21 +1100" MODIFIED_BY="Narelle S Willis" NOTES="&lt;p&gt;Rosman JB, Langer K, Brandl M, Piers -Becht TP, Van der Hem GK, Ter Wee PM, Donker AJM. Protein-restricted diets in chronic renal failure: A four year follow-up shows limited indications. Kidney Int 1989, 36-S27: S96-S102&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-11-26 13:58:21 +1100" NOTES_MODIFIED_BY="Narelle S Willis" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rosman JB, Langer K, Brandl M, Piers-Becht TP, Van der Hem GK, Ter Wee PM et al</AU>
<TI>Protein-restricted diets in chronic renal failure: A four year follow-up shows limited indications</TI>
<SO>Kidney International - Supplement</SO>
<YR>1989</YR>
<VL>27</VL>
<PG>96-102</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2636680"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 14:11:06 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosman JB, ter Wee PM, Meijer S, Piers-Becht TP, Sluiter WJ, Donker AJ</AU>
<TI>Prospective randomised trial of early dietary protein restriction in chronic renal failure</TI>
<SO>Lancet</SO>
<YR>1984</YR>
<VL>324</VL>
<NO>8415</NO>
<PG>1291-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 14:11:06 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rosman JB, ter Wee PM, Piers-Becht GP, Sluiter WJ, van der Woude FJ, Meijer S, et al</AU>
<TI>Early protein restriction in chronic renal failure</TI>
<SO>Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association</SO>
<YR>1985</YR>
<VL>21</VL>
<PG>567-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-1991" MODIFIED="2008-11-26 14:22:46 +1100" MODIFIED_BY="Narelle S Willis" NAME="Williams 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-11-26 14:22:46 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams PS, Stevens M, Irons L, Fass G, Bone JM</AU>
<TI>Failure of Dietary Protein/Phosphate Restriction to Slow the Progression of Chronic Renal Failure; A Prospective Randomised Controlled Trial [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1990</YR>
<VL>5</VL>
<NO>8</NO>
<PG>674</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Williams PS, Stevens ME, Fass G, Irons L, Bone JM. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Q J Med 1991,81:837-855&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams PS, Stevens ME, Fass G, Irons L, Bone JM</AU>
<TI>Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial</TI>
<SO>Quarterly Journal of Medicine</SO>
<YR>1991</YR>
<VL>81</VL>
<NO>294</NO>
<PG>837-55</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1801057"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 14:22:46 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams PS, Stevens ME</AU>
<TI>A Randomised Trial of the Effect of Protein and Phosphate Restriction on the Progression of Chronic Renal Failure [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1987</YR>
<VL>2</VL>
<NO>5</NO>
<PG>401</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2009-04-08 10:32:55 +1000" MODIFIED_BY="Narelle S Willis">
<STUDY DATA_SOURCE="PUB" ID="STD-Alvestrand-1980" NAME="Alvestrand 1980" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;Alvestrand A, Ahlberg M, Furst P, Bergstrom J. Clinical experience with amino acids and keto acids diets. Am J Clin Nutr 1980;33:1654-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alvestrand A, Ahlberg M, Furst P, Bergstrom J</AU>
<TI>Clinical experience with amino acid and keto acid diets</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1980</YR>
<VL>33</VL>
<NO>7</NO>
<PG>1654-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7395786"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alvestrand-1983" NAME="Alvestrand 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;Alvestrand A, Ahlberg M, Bergstrom J. Retardation of the progression of renal insufficiency in patients treated with low-protein diets. Kidney Int 1983 S16:268-272&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alvestrand A, Ahlberg M, Bergstrom J</AU>
<TI>Retardation of the progression of renal insufficiency in patients treated with low-protein diets</TI>
<SO>Kidney International - Supplement</SO>
<YR>1983</YR>
<VL>16</VL>
<PG>268-72</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6588263"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Attman-1983" NAME="Attman 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;Attman PO, Bucht H, Larsson O, Uddebom G. Protein-reduced diet in diabetic renal failure. Clin Nephrol 1983;19:217-20.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Attman PO, Bucht H, Larsson O, Uddebom G</AU>
<TI>Protein-reduced diet in diabetic renal failure</TI>
<SO>Clinical Nephrology</SO>
<YR>1983</YR>
<VL>19</VL>
<NO>5</NO>
<PG>217-20</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6851260"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Attman-1986" NAME="Attman 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Attman P.O. Long term treatment with low protein diet in uremia. Contrib Nephrol 1986;53:128-136.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Attman PO</AU>
<TI>Long term treatment with low protein diet in uremia</TI>
<SO>Contributions to Nephrology</SO>
<YR>1986</YR>
<VL>53</VL>
<PG>128-36</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3802819"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barsotti-1981" NAME="Barsotti 1981" YEAR="1981">
<REFERENCE NOTES="&lt;p&gt;Barsotti G, Guiducci A, Ciardella F, Giovanetti S. Effects on renal function of a low nitrogen diet supplemented with essential Amino Acids and Ketoanalogues and of hemodialysis and free protein supply in patients with chronic renal failure. Nephron 1981 ;27:113-117.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barsotti G, Guiducci A, Ciardella F, Giovanetti S</AU>
<TI>Effects on renal function of a low nitrogen diet supplemented with essential amino acids and ketoanalogues and of hemodialysis and free protein supply in patients with chronic renal failure</TI>
<SO>Nephron</SO>
<YR>1981</YR>
<VL>27</VL>
<NO>3</NO>
<PG>113-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7219640"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barsotti G, Morelli E, Giannoni A, Guiducci A, Lupetti S, Giovannetti S</AU>
<TI>Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure, a controlled trial</TI>
<SO>Kidney International - Supplement</SO>
<YR>1983</YR>
<VL>16</VL>
<PG>278-84</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6376918"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barsotti-1984" NAME="Barsotti 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Barsotti G, Giannoni A, Morelli E et al. The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet. Clin Nephrol 1984;21:54-59.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barsotti G, Giannoni A, Morelli E, Lazzeri M, Vlamis I, Baldi R et al</AU>
<TI>The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet</TI>
<SO>Clinical Nephrology</SO>
<YR>1984</YR>
<VL>21</VL>
<NO>1</NO>
<PG>54-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6705274"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barsotti-1988" NAME="Barsotti 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Barsotti G, Ciardella F, Morelli E, Cupisti A, Mantovanelli A, Giovanetti S. Nutritional treatment of renal failure in type 1 diabetic nephropathy. Clin Nephrol 1988;29:280-7&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barsotti G, Ciardella F, Morelli E, Cupisti A, Mantovanelli A, Giovanetti S</AU>
<TI>Nutritional treatment of renal failure in type 1 diabetic nephropathy</TI>
<SO>Clinical Nephrology</SO>
<YR>1988</YR>
<VL>29</VL>
<NO>6</NO>
<PG>280-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3396230"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bellizzi-2007" MODIFIED="2008-11-26 13:49:49 +1100" MODIFIED_BY="Narelle S Willis" NAME="Bellizzi 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-11-26 13:49:49 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bellizzi V, Di Iorio BR, De Nicola L, Minutolo R, Zamboli P, Trucillo P, et al</AU>
<TI>Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease.[see comment]</TI>
<SO>Kidney International</SO>
<YR>2007</YR>
<VL>71</VL>
<NO>3</NO>
<PG>245-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bennett-1983" NAME="Bennett 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;Bennett SE, Russell GI, Walls J. Low protein diets in uremia. BMJ 1983;287:1344-5&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bennett SE, Russell GI, Walls J</AU>
<TI>Low protein diets in uraemia</TI>
<SO>British Medical Journal Clinical Research Ed</SO>
<YR>1983</YR>
<VL>287</VL>
<NO>6402</NO>
<PG>1344-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6416404"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bergstrom-1989" MODIFIED="2008-11-26 13:50:18 +1100" MODIFIED_BY="Narelle S Willis" NAME="Bergstrom 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-11-26 13:50:18 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bergstrom J, Alvestrand A, Bucht H, Gutierrez A</AU>
<TI>Stockholm clinical study on progression of chronic renal failure--an interim report</TI>
<SO>Kidney International - Supplement</SO>
<YR>1989</YR>
<VL>36</VL>
<NO>Suppl 27</NO>
<PG>S110-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bernhard-2001" MODIFIED="2008-11-26 13:52:06 +1100" MODIFIED_BY="Narelle S Willis" NAME="Bernhard 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-11-26 13:52:06 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bernhard J, Beaufrere B, Laville M, Fouque D</AU>
<TI>Adaptive response to a low-protein diet in predialysis chronic renal failure patients</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>6</NO>
<PG>1249-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brunori-2003" NAME="Brunori 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brunori G, Viola F, Zubani R, de Biase V, Franco V, Cuoma D et al</AU>
<TI>The DODE Study (diet or dialysis in elderly): interim analysis [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>2003</YR>
<VL>18 Suppl</VL>
<NO>4</NO>
<PG>440</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burns-1978" NAME="Burns 1978" YEAR="1978">
<REFERENCE NOTES="&lt;p&gt;Burns et al. Comparison of the effects of ketoacids analogues and essential aminoacids on nitrogen homeostasis in uremic patients on moderately protein-restricted diets. Am J Clin Nutr 1978;31:1767-75.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burns J, Cresswell E, Ell S, Fynn M, Jackson MA, Lee HA et al</AU>
<TI>Comparison of the effects of keto acid analogues and essential amino acids on nitrogen homeostasis in uremic patients on moderately protein-restricted diets</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1978</YR>
<VL>31</VL>
<NO>10</NO>
<PG>1767-75</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="707331"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coresh-1994" MODIFIED="2008-11-26 13:57:09 +1100" MODIFIED_BY="Narelle S Willis" NAME="Coresh 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-11-26 13:57:09 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coresh J, Walser M, Hill S</AU>
<TI>Long-term outcome of treatment of chronic renal failure with a supplemented low protein diet [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1994</YR>
<VL>5</VL>
<NO>3</NO>
<PG>489</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-D_x0027_Amico-1994" NAME="D'Amico 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;D'Amico G, Gentile MG, Fellin G, Manna G, Cofano F. Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrol Dial Transplant 1994, 9:1590-1594&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>D'Amico G, Gentile MG, Fellin G, Manna G, Cofano F</AU>
<TI>Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1994</YR>
<VL>9</VL>
<NO>11</NO>
<PG>1590-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7870348"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dek-1998" NAME="Dek 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Dek K, Gullulu M, Yavuz M, Ersoy A, Karakoc Y, Dalk E, Yurtkuran M</AU>
<TI>The effects of low dose proteinaceous diet and essential amino acid ketoanologue therapy on the metabolism of lipid and insulin resistance in predialysis patients [abstract]</TI>
<SO>XXXV ERA-EDTA; 1998; Jun 6-9; Rimini (Italy)</SO>
<YR>1998</YR>
<PG>161</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Di-Landro-1986" NAME="Di Landro 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Di Landro D, Perin N, Bertoli M et al. Clinical effects of a low protein diet supplemented with essential amino acids and keto analogues in uremic patients. Contrib Nephrol Basel 1986;53:137-143.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Di Landro D, Perin N, Bertoli M, Gasparotti ML, Ruffatti A, Naso A et al</AU>
<TI>Clinical effects of a low protein diet supplemented with essential amino acids and keto analogues in uremic patients</TI>
<SO>Contributions to Nephrology</SO>
<YR>1986</YR>
<VL>53</VL>
<PG>137-43</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3802820"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-DODE-Study-2007" MODIFIED="2008-11-26 14:04:44 +1100" MODIFIED_BY="Narelle S Willis" NAME="DODE Study 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-11-26 13:54:09 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brunori G, Viola BF, Parrinello G, De B, Como G, Franco V, et al</AU>
<TI>Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study.[see comment]</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>2007</YR>
<VL>49</VL>
<NO>5</NO>
<PG>569-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 14:04:44 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maiorca R, Brunori G, Viola BF, Zubani R, Cancarini G, Parrinello G, et al</AU>
<TI>Diet or dialysis in the elderly? The DODE study: a prospective randomized multicenter trial</TI>
<SO>Journal of Nephrology</SO>
<YR>2000</YR>
<VL>13</VL>
<NO>4</NO>
<PG>267-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El-Nahas-1984" NAME="El Nahas 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;El Nahas AM, Masters-Thomas A, Brady SA et al. Selective effect of low protein diets in chronic renal diseases. BMJ 1984;289:1337-41.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El Nahas AM, Masters-Thomas A, Brady SA, Farrington K, Wilkinson V, Hilson AJ et al</AU>
<TI>Selective effect of low protein diets in chronic renal diseases</TI>
<SO>British Medical Journal Clinical Research Ed</SO>
<YR>1984</YR>
<VL>289</VL>
<NO>6455</NO>
<PG>1337-41</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6437539"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Esaian-2002" NAME="Esaian 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Esaian AM, Kucher AG, Kaiukov IG, Ermakov I, Nikogosian I, Riabov SI</AU>
<TI>Effect of protein load on kidney functions in patients with chronic glomerulonephritis</TI>
<SO>Terapevticheskii Arkhiv</SO>
<YR>2002</YR>
<VL>74</VL>
<NO>6</NO>
<PG>19-24</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12136476"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frohling-1980" NAME="Frohling 1980" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;Frohling PT, Schmicker R, Vetter Ket al. Conservative treatment with ketoacid and aminoacid supplemented low-protein diets in chronic renal failure. Am J Clin Nutr 1980;33:1667-72.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frohling PT, Schmicker R, Vetter K, Kaschube I, Gotz KH, Jacopian M et al</AU>
<TI>Conservative treatment with ketoacid and amino acid supplemented low-protein diets in chronic renal failure</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1980</YR>
<VL>33</VL>
<NO>7</NO>
<PG>1667-72</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7395787"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frohling-1983" NAME="Frohling 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;Frohling PT, Kokot F, Smicker R, Kaschube I, Lindenau K, Vetter K. Influence of ketoacids on serum parathyroid hormone levels in patients with chronic renal failure. Clin Nephrol 1983;20:212-15.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frohling PT, Kokot F, Schmicker R, Kaschube I, Lindenau K, Vetter K</AU>
<TI>Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure</TI>
<SO>Clinical Nephrology</SO>
<YR>1983</YR>
<VL>20</VL>
<NO>4</NO>
<PG>212-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6641029"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frohling-1989" NAME="Frohling 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Frohling PT, Lindenau K, Vetter K, Krupki F, Schmicker R. What can be safely said about predialysis treatment? Blood Purif 1989;7:28-32.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frohling PT, Lindenau K, Vetter K, Krupki F, Schmicker R</AU>
<TI>What can be safely said about predialysis treatment?</TI>
<SO>Blood Purification</SO>
<YR>1989</YR>
<VL>7</VL>
<NO>1</NO>
<PG>28-32</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2920099"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fuessl-2006" MODIFIED="2008-11-26 14:00:42 +1100" MODIFIED_BY="Narelle S Willis" NAME="Fuessl 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-11-26 14:00:42 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fuessl HS</AU>
<TI>[Egg white-poor diet in kidney failure: annoyance or meaningful measure?]. [German]</TI>
<SO>MMW Fortschritte der Medizin</SO>
<YR>2006</YR>
<VL>148</VL>
<NO>26</NO>
<PG>4-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gretz-1983" MODIFIED="2009-04-08 10:32:55 +1000" MODIFIED_BY="Narelle S Willis" NAME="Gretz 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;Gretz N, Korb E, Strauch M. Low-protein diet supplemented by keto acids in chronic renal failure, a prospective controlled study. Kidney Int Suppl 1983;16:263-67.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gretz N, Korb E, Strauch M</AU>
<TI>Low-protein diet supplemented by keto acids in chronic renal failure, a prospective controlled study</TI>
<SO>Kidney International - Supplement</SO>
<YR>1983</YR>
<VL>16</VL>
<PG>263-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6376916"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-04-08 10:32:55 +1000" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Gretz N, Korb E, Strauch M</AU>
<TI>Protein restricted diet supplemented by keto-acids in chronic renal failure: a prospective controlled study [abstract]</TI>
<SO>19th Annual Scientific Meeting of the Australasian Society of Nephrology</SO>
<YR>1983</YR>
<PG>30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gretz N, Meisinger E, Strauch M</AU>
<TI>Does a low protein diet really slow down the rate of progression of chronic renal failure?</TI>
<SO>Blood Purification</SO>
<YR>1989</YR>
<VL>7</VL>
<NO>1</NO>
<PG>33-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2645923"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gretz N, Meisinger E, Strauch M</AU>
<TI>Influence of diet and underlying renal disease on the rate of progression of chronic renal failure</TI>
<SO>Infusionstherapie Und Klinische Ernahrung</SO>
<YR>1987</YR>
<VL>14 Suppl</VL>
<NO>5</NO>
<PG>21-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3436665"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gretz N, Meisinger E, Strauch M</AU>
<TI>Influence of the underlying renal disease on the rate of progression</TI>
<SO>Contributions to Nephrology</SO>
<YR>1986</YR>
<VL>53</VL>
<PG>92-101</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3542381"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gretz N, Strauch M</AU>
<TI>Delayed progression of chronic renal failure, a prospective controlled trial with a low protein diet supplemented by keto acids</TI>
<SO>Contributions to Nephrology</SO>
<YR>1985</YR>
<VL>49</VL>
<PG>78-86</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3830572"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hecking-1980" NAME="Hecking 1980" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;Hecking E, Andrzejewski LI, Prellnitz W, Opferkuch W, Muller D. Double blind cross over study with oral and ketoacids in patients with chronic renal failure. Am J Clin Nutr 1980;33:1678-81.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hecking E, Andrzejewski L, Prellwitz W, Opferkuch W, Muller D</AU>
<TI>Double-blind cross-over study with oral alpha-ketoacids in patients with chronic renal failure</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1980</YR>
<VL>33</VL>
<NO>7</NO>
<PG>1678-81</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6994475"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-IRCCA-Study-1988" MODIFIED="2008-11-26 14:00:13 +1100" MODIFIED_BY="Narelle S Willis" NAME="IRCCA Study 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-11-26 14:00:13 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forget D, Caranhac G, Quillot MJ, Besnier MO</AU>
<TI>Compliance with very low protein diet and ketoanalogues in chronic renal failure. The French Multicentric Trial IRCCA</TI>
<SO>Contributions to Nephrology</SO>
<YR>1990</YR>
<VL>81</VL>
<PG>79-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 13:59:01 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forget D, Caranhac G, Quillot MJ</AU>
<TI>French multicentric trial (IRCCA) for testing a new ketoanalog and essential amino acid mixture in patients with chronic renal failure. [abstract]</TI>
<SO>Kidney International</SO>
<YR>1988</YR>
<VL>36</VL>
<NO>Suppl 27</NO>
<PG>S300</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ivarsen-1995" MODIFIED="2008-11-26 14:03:46 +1100" MODIFIED_BY="Narelle S Willis" NAME="Ivarsen 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-11-26 14:03:46 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ivarsen P, Pedersen EB</AU>
<TI>Effect of protein supplement on nutritional status in hemodialysis patients [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1995</YR>
<VL>6</VL>
<NO>3</NO>
<PG>579</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kampf-1980" NAME="Kampf 1980" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;Kampf D, Fischer HC, Kessel M. Efficacy of an unselected protein diet (25 g) with minor oral supply of essential amino acids and ketoanalogues compared with a selective protein diet (40 g) in chronic renal failure. Am J Clin Nutr 1980;33:1673-77.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kampf D, Fischer HC, Kessel M</AU>
<TI>Efficacy of an unselected protein diet (25 g) with minor oral supply of essential amino acids and keto analogues compared with a selective protein diet (40 g) in chronic renal failure</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1980</YR>
<VL>33</VL>
<NO>7</NO>
<PG>1673-77</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7395788"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levine-1989" NAME="Levine 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Levine SE, D'Elia JA, Bistrian B et al. Protein restricted diets in diabetic nephropathy. Nephron 1989;52:55-61.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levine SE, D'Elia JA, Bistrian B, Smith-Ossman S, Gleason R, Mitch WE et al</AU>
<TI>Protein restricted diets in diabetic nephropathy</TI>
<SO>Nephron</SO>
<YR>1989</YR>
<VL>52</VL>
<NO>1</NO>
<PG>55-61</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2710267"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lim-2000" NAME="Lim 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Lim CS, Norashikin AB, Noor Aini MY, Zahara AM, Angl BB, Aparicio M et al</AU>
<TI>The effect of very low protein supplemented by ketoamino acid versus low protein diet on progression of chronic renal failure</TI>
<SO>13th Asian Colloquium in Nephrology; 2000 Nov 23-25; Bali (Indonesia)</SO>
<YR>2000</YR>
<PG>68</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Noor Aini MY, Zahara AM, Norashikin AB, Lim CS, Ang BB, Aparicio M et al</AU>
<TI>Dietary changes and nutritional status of chronic renal failure patients on very low protein diet supplemented by ketoamino acid versus low protein diet</TI>
<SO>13th Asian Colloquium in Nephrology; 2000 Nov 23-25; Bali (Indonesia)</SO>
<YR>2000</YR>
<PG>140</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lucas-1986" NAME="Lucas 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Lucas PA, Meadows JH, Roberts DE, Coles GA. The risks and benefits of a low protein-essential amino acid-keto acid diet. Kidney Int 1986;29:995-1003.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lucas PA, Meadows JH, Roberts DE, Coles GA</AU>
<TI>The risks and benefits of a low protein-essential amino acid-keto acid diet</TI>
<SO>Kidney International</SO>
<YR>1986</YR>
<VL>29</VL>
<NO>5</NO>
<PG>995-1003</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3723930"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maksic-2004" MODIFIED="2009-04-08 10:23:55 +1000" MODIFIED_BY="Narelle S Willis" NAME="Maksic 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-04-08 10:23:55 +1000" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Maksic D, Pavlovic G, Kostic-Milosavljevic M, Mijuskovic Z, Radjen S, Bokonjic D et al</AU>
<TI>Comparison of effects of low protein diet (lpd) and very low protein diet (vlpd) supplemented with essential and ketoanalogue amino acids on the progression of predialysis chronic renal failure [abstract]</TI>
<SO>ERA - EDTA Congress; 2004; May 15-18; Lisbon (Portugal)</SO>
<YR>2004</YR>
<PG>296</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maroni-1997" MODIFIED="2008-11-26 14:22:12 +1100" MODIFIED_BY="Narelle S Willis" NAME="Maroni 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-11-26 14:06:34 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maroni BJ, Staffeld C, Young VR, Manatunga A, Tom K</AU>
<TI>Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet</TI>
<SO>Journal of Clinical Investigation</SO>
<YR>1997</YR>
<VL>99</VL>
<NO>10</NO>
<PG>2479-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 14:22:12 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tom K, Young VR, Umeakunne K, Maroni BJ</AU>
<TI>Anabolic responses activated in nephrotic patients fed a protein-restricted diet [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1994</YR>
<VL>5</VL>
<NO>3</NO>
<PG>343</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maschio-1982" NAME="Maschio 1982" YEAR="1982">
<REFERENCE NOTES="&lt;p&gt;Maschio G, Oldrizzi L, Tessitore N et al. Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney Int 1982;22:371-76.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maschio G, Oldrizzi L, Tessitore N, D'Angelo A, Valvo E, Lupo A et al</AU>
<TI>Effects of dietary protein and phosphorus restriction on the progression of early renal failure</TI>
<SO>Kidney International</SO>
<YR>1982</YR>
<VL>22</VL>
<NO>4</NO>
<PG>371-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7176336"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Masud-1992" NAME="Masud 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Masud T, Young VR, Maroni BJ</AU>
<TI>Metabolic responses to protein restriction: the first comparison of ketoacids (ka) with essential amino acids (eaa) [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1992</YR>
<VL>3</VL>
<NO>3</NO>
<PG>286</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meisinger-1987" NAME="Meisinger 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Meisinger E, Strauch M.Controlled trial of two keto acid supplements on renal function, nutritional status, and bone metabolism in uremic patients. Kidney Int 1987;22:170-73.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meisinger E, Strauch M</AU>
<TI>Controlled trial of two keto acid supplements on renal function, nutritional status, and bone metabolism in uremic patients</TI>
<SO>Kidney International - Supplement</SO>
<YR>1987</YR>
<VL>22</VL>
<PG>170-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3323611"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mitch-1984" NAME="Mitch 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Mitch WE, Walser M, Steinman TI, Hill S, Zeger S, Tungsanga K. The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure. N Engl J Med 1984;6:623-29.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mitch WE, Walser M, Steinman TI, Hill S, Zeger S, Tungsanga K</AU>
<TI>The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure</TI>
<SO>New England Journal of Medicine</SO>
<YR>1984</YR>
<VL>6</VL>
<NO>10</NO>
<PG>623-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="6472341"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moreira-2007" MODIFIED="2008-11-26 14:08:31 +1100" MODIFIED_BY="Narelle S Willis" NAME="Moreira 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-11-26 14:08:31 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moreira AC, Gaspar A, Serra MA, Simoes J, Lopes da Cruz, Freitas do Amaral T</AU>
<TI>Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis</TI>
<SO>Journal of Renal Nutrition</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>3</NO>
<PG>205-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oldrizzi-1985" NAME="Oldrizzi 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;Oldrizzi L, Rugiu C, Valvo E et al. Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet. Kidney Int 1985;27:553-57.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oldrizzi L, Rugiu C, Valvo E, Lupo A, Loschiavo C, Gammaro L et al</AU>
<TI>Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet</TI>
<SO>Kidney International</SO>
<YR>1985</YR>
<VL>27</VL>
<NO>3</NO>
<PG>553-57</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3999543"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patel-2000" MODIFIED="2008-10-14 10:56:00 +1100" MODIFIED_BY="[Empty name]" NAME="Patel 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-10-14 10:56:00 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Patel Z, Bhattacharjee LI, Shah BV</AU>
<TI>The role of dietary protein restriction in Indian patients with chronic renal failure</TI>
<SO>Journal of the Association of Physicians of India</SO>
<YR>2000</YR>
<VL>48</VL>
<NO>11</NO>
<PG>1078-81</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:56:00 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="21205533"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prakash-2003" MODIFIED="2008-10-14 10:56:07 +1100" MODIFIED_BY="[Empty name]" NAME="Prakash 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-10-14 10:56:07 +1100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prakash S, Pande D, Suresh K, Kulkarni H</AU>
<TI>Randomized double blind placebo controlled trial of ketoanalogues in retardation of chronic renal failure in tropics [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>2003</YR>
<VL>18 Suppl</VL>
<NO>4</NO>
<PG>130</PG>
<IDENTIFIERS MODIFIED="2008-10-14 10:56:07 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 10:56:07 +1100" MODIFIED_BY="[Empty name]" TYPE="CENTRAL" VALUE="CN-00447278"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;. Randomized, double-blind, placebo-controlled trial to evaluate efficacy of ketodiet in predialytic chronic renal failure. [Clinical Trial. Journal Article. Randomized Controlled Trial] Journal of Renal Nutrition. 14(2):89-96, 2004 Apr 15060873&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prakash S, Pande DP, Sharma S, Sharma D, Bal CS, Kulkarni H</AU>
<TI>Randomized, double-blind, placebo-controlled trial to evaluate efficacy of ketodiet in predialytic chronic renal failure</TI>
<SO>Journal of Renal Nutrition</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>2</NO>
<PG>89-96</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="15060873"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Riabov-2001" NAME="Riabov 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Riabov SI, Kucher AG, Grigor'eva ND, Kaiukov IG, Ermakov I</AU>
<TI>Effects of different variants of low-protein diet on progression of chronic renal failure and indices of nutritional status in predialysis stage</TI>
<SO>Terapevticheskii Arkhiv</SO>
<YR>2001</YR>
<VL>73</VL>
<NO>6</NO>
<PG>10-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11521513"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanfelippo-1978" MODIFIED="2008-11-26 14:13:03 +1100" MODIFIED_BY="Narelle S Willis" NAME="Sanfelippo 1978" YEAR="1978">
<REFERENCE MODIFIED="2008-11-26 14:13:03 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanfelippo ML, Swenson RS, Reaven GM</AU>
<TI>Plasma triglyceride (TG) and insulin responses to diet in dialyzed subjects with end stage renal failure. [abstract]</TI>
<SO>Kidney International</SO>
<YR>1976</YR>
<VL>10</VL>
<PG>525</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 14:12:58 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanfelippo ML, Swenson RS, Reaven GM</AU>
<TI>Response of plasma triglycerides to dietary change in patients on hemodialysis</TI>
<SO>Kidney International</SO>
<YR>1978</YR>
<VL>14</VL>
<NO>2</NO>
<PG>180-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schmicker-1986" NAME="Schmicker 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Schmicker R, Frohling PT, Goetz KH, Kaschube I, Rakette I, Vetter K. Influence of low protein diet supplemented with amino acids and keto acids on the progression of chronic renal failure. Contrib Nephrol 1986;53:121-27.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmicker R, Frohling PT, Goetz KH, Kaschube I, Rakette I, Vetter K</AU>
<TI>Influence of low protein diet supplemented with amino acids and keto acids on the progression of chronic renal failure</TI>
<SO>Contributions to Nephrology</SO>
<YR>1986</YR>
<VL>53</VL>
<PG>121-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3542378"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schmicker R, Vetter K, Lindenau K, Frohling PT, Kobot F</AU>
<TI>Conservative long-term treatment of chronic renal failure with keto acid and amino acid supplementation</TI>
<SO>Infusionstherapie und Klinische Ernahrung</SO>
<YR>1987</YR>
<VL>14 Suppl</VL>
<NO>5</NO>
<PG>34-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3125108"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Teplan-2003" MODIFIED="2008-11-26 14:16:30 +1100" MODIFIED_BY="Narelle S Willis" NAME="Teplan 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-11-26 14:16:30 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Teplan V, Schuck O, Knotek A, Hajny J, Horackova M, Kvapil M</AU>
<TI>Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low-protein diet: Czech multicenter study</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>2003</YR>
<VL>41</VL>
<NO>3 Suppl 2</NO>
<PG>26-30</PG>
<IDENTIFIERS MODIFIED="2008-11-26 14:16:30 +1100" MODIFIED_BY="Narelle S Willis">
<IDENTIFIER TYPE="MEDLINE" VALUE="22498947"/>
<IDENTIFIER MODIFIED="2008-11-26 14:16:30 +1100" MODIFIED_BY="Narelle S Willis" TYPE="OTHER" VALUE="CN-00413403"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-26 14:14:46 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Teplan V, Schuck O, Knotek A, Hajny J, Horackova M</AU>
<TI>Ketoacids and recombinant human erythro-poietin may in fluence progression of chronic renal incufficiency: czech multicentre study [abstract]</TI>
<SO>XXXVIII ERA-EDTA; 2001 Jun 24-27; Vienna (Austria)</SO>
<YR>2001</YR>
<PG>145</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Teplan-2006" MODIFIED="2008-11-26 14:19:06 +1100" MODIFIED_BY="Narelle S Willis" NAME="Teplan 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-11-26 14:19:06 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Teplan V, Schuck O, Hanzal V, Hajny J, Horackova M, Ryba M, et al</AU>
<TI>[Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study]. [Czech]</TI>
<SO>Vnitrni Lekarstvi</SO>
<YR>2006</YR>
<VL>52</VL>
<NO>6</NO>
<PG>571-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Terzi-1995" NAME="Terzi 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Terzi F, Dartois AM, Broyer M, Niaudet P, Claris-Appiani C, Dechaux M et al</AU>
<TI>Growth in uremia: an unsolved enigma. Study with two low protein diets in infancy [abstract]</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>1995</YR>
<VL>6</VL>
<NO>3</NO>
<PG>404</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walser-1975" NAME="Walser 1975" YEAR="1975">
<REFERENCE NOTES="&lt;p&gt;Walser M. Ketoacids in the treatment of uremia. Clin Nephrol 1975;3:180-86.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walser M</AU>
<TI>Ketoacids in the treatment of uremia</TI>
<SO>Clinical Nephrology</SO>
<YR>1975</YR>
<VL>3</VL>
<NO>5</NO>
<PG>180-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1149342"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walser-1987" NAME="Walser 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Walser M, LaFrance N, Ward L, VanDuyn MA. Progression of chronic renal failure in patients given keto acids following amino acids. Infusionstherapie und Klinische Ernahrung 1987;14-Suppl 5;17-20.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walser M, LaFrance N, Ward L, Van Duyn MA</AU>
<TI>Progression of chronic renal failure in patients given keto acids following amino acids</TI>
<SO>Infusionstherapie und Klinische Ernahrung</SO>
<YR>1987</YR>
<VL>14 Suppl</VL>
<NO>5</NO>
<PG>17-20</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3436664"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wingen-1997" NAME="Wingen 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Wingen AM, Fabian-Bach C, Schafer F, Mehls O. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. Lancet 1997, 349:1117-1123.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wingen AM, Fabian-Bach C, Schafer F, Mehls O</AU>
<TI>Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children</TI>
<SO>Lancet</SO>
<YR>1997</YR>
<VL>349</VL>
<NO>9059</NO>
<PG>1117-23</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9113009"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Younes-2006" MODIFIED="2008-11-26 14:24:03 +1100" MODIFIED_BY="Narelle S Willis" NAME="Younes 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-11-26 14:24:03 +1100" MODIFIED_BY="Narelle S Willis" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Younes H, Egret N, Hadj-Abdelkader M, Remesy C, Demigne C, Gueret C, et al</AU>
<TI>Fermentable carbohydrate supplementation alters nitrogen excretion in chronic renal failure</TI>
<SO>Journal of Renal Nutrition</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>1</NO>
<PG>67-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zakar-1984" NAME="Zakar 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Zakar G. Effects of dietary protein restriction on the course of early renal failure. Proceedings EDTA-ERA, London:Pitman 1984;21:600-603.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zakar G</AU>
<TI>Effects of dietary protein restriction on the course of early renal failure</TI>
<SO>Proceedings of the European Dialysis &amp; Transplant Association - European Renal Association</SO>
<YR>1984</YR>
<VL>21</VL>
<PG>600-3</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3991551"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeller-1991" NAME="Zeller 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991;324:78-84&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR</AU>
<TI>Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus</TI>
<SO>New England Journal of Medicine</SO>
<YR>1991</YR>
<VL>324</VL>
<NO>2</NO>
<PG>78-84</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1984187"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-04-21 08:57:01 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-10-14 10:56:44 +1100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Altman-1999" NAME="Altman 1999" TYPE="JOURNAL_ARTICLE">
<AU>Altman DG, Andersen PK</AU>
<TI>Calculating the number needed to treat for trials where the outcome is time to an event</TI>
<SO>BMJ</SO>
<YR>1999</YR>
<VL>319</VL>
<NO>7223</NO>
<PG>1492-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10582940"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Aparicio-2000" NAME="Aparicio 2000" TYPE="JOURNAL_ARTICLE">
<AU>Aparicio M, Chauveau P, De Precigout V, Bouchet JL, Lasseur C, Combe C</AU>
<TI>Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet</TI>
<SO>Journal of the American Society of Nephrology</SO>
<YR>2000</YR>
<VL>11</VL>
<NO>4</NO>
<PG>708-16</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10752530"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Boissel-1989" MODIFIED="2008-10-14 10:56:17 +1100" MODIFIED_BY="[Empty name]" NAME="Boissel 1989" TYPE="JOURNAL_ARTICLE">
<AU>Boissel JP, Blanchard J, Panak E, Peyrieux JC, Sacks H</AU>
<TI>Considerations for the meta-analysis of randomized clinical trials, summary of a panel discussion</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1989</YR>
<VL>10</VL>
<NO>3</NO>
<PG>254-81</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2791560"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-DOQI-2000" MODIFIED="2008-10-14 10:56:24 +1100" MODIFIED_BY="[Empty name]" NAME="DOQI 2000" TYPE="JOURNAL_ARTICLE">
<AU>Anonymous</AU>
<TI>Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>2000</YR>
<VL>35</VL>
<NO>6 Suppl 2</NO>
<PG>1-140</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10895784"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9310563"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fouque-1992" MODIFIED="2008-10-14 10:56:28 +1100" MODIFIED_BY="[Empty name]" NAME="Fouque 1992" TYPE="JOURNAL_ARTICLE">
<AU>Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw M, Zech PY</AU>
<TI>Controlled low protein diets in chronic renal insufficiency: meta-analysis</TI>
<SO>BMJ</SO>
<YR>1992</YR>
<VL>304</VL>
<NO>6821</NO>
<PG>216-20</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1531426"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Gansevoort-1995" NAME="Gansevoort 1995" TYPE="JOURNAL_ARTICLE">
<AU>Gansevoort RT, de Zeeuw D, de Jong PE</AU>
<TI>Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1995</YR>
<VL>10</VL>
<NO>4</NO>
<PG>497-504</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="7623991"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2008-10-14 10:56:31 +1100" MODIFIED_BY="[Empty name]" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="12958120"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kasiske-1998" MODIFIED="2008-10-14 10:56:34 +1100" MODIFIED_BY="[Empty name]" NAME="Kasiske 1998" TYPE="JOURNAL_ARTICLE">
<AU>Kasiske BL, Lakatua JDA, Ma JZ, Louis TA</AU>
<TI>A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>1998</YR>
<VL>31</VL>
<NO>6</NO>
<PG>954-61</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9631839"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Klahr-1989" NAME="Klahr 1989" TYPE="JOURNAL_ARTICLE">
<AU>Klahr S</AU>
<TI>The modification of diet in renal disease study</TI>
<SO>New England Journal of Medicine</SO>
<YR>1989</YR>
<VL>320</VL>
<NO>13</NO>
<PG>864-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="2494456"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kopple-1997" MODIFIED="2008-10-14 10:56:37 +1100" MODIFIED_BY="[Empty name]" NAME="Kopple 1997" TYPE="JOURNAL_ARTICLE">
<AU>Kopple JD, Levey AS, Greene T, Chumlea WC, Gassman JJ, Hollinger DL et al</AU>
<TI>Effect of dietary protein restriction on nutritional status in the modification of diet in Renal Disease study</TI>
<SO>Kidney International</SO>
<YR>1997</YR>
<VL>52</VL>
<NO>3</NO>
<PG>778-91</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9291200"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kopple-2000" NAME="Kopple 2000" TYPE="JOURNAL_ARTICLE">
<AU>Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D et al</AU>
<TI>Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study</TI>
<SO>Kidney International</SO>
<YR>2000</YR>
<VL>57</VL>
<NO>4</NO>
<PG>1688-703</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10760105"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Locatelli-1999" NAME="Locatelli 1999" TYPE="JOURNAL_ARTICLE">
<AU>Locatelli F, Del Vecchio L</AU>
<TI>How long can dialysis be postponed by low protein diet and ACE inhibitors?</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>6</NO>
<PG>1360-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="10382993"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pedrini-1996" MODIFIED="2008-10-14 10:56:41 +1100" MODIFIED_BY="[Empty name]" NAME="Pedrini 1996" TYPE="JOURNAL_ARTICLE">
<AU>Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH</AU>
<TI>The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1996</YR>
<VL>124</VL>
<NO>7</NO>
<PG>627-32</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="96201235"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sacks-1987" MODIFIED="2008-10-14 10:56:44 +1100" MODIFIED_BY="[Empty name]" NAME="Sacks 1987" TYPE="JOURNAL_ARTICLE">
<AU>Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC</AU>
<TI>Meta-analyses of randomized controlled trials</TI>
<SO>New England Journal of Medicine</SO>
<YR>1987</YR>
<VL>316</VL>
<NO>8</NO>
<PG>450-55</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="3807986"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Skolbekken-1998" NAME="Skolbekken 1998" TYPE="JOURNAL_ARTICLE">
<AU>Skolbekken JA</AU>
<TI>Communicating the risk reduction achieved by cholesterol reducing drugs</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>316</VL>
<NO>7149</NO>
<PG>1956-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9641937"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2009-03-31 15:39:33 +1100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Fouque-2000a" MODIFIED="2008-10-14 11:03:56 +1100" MODIFIED_BY="[Empty name]" NAME="Fouque 2000a" TYPE="JOURNAL_ARTICLE">
<AU>Fouque D, Wang P, Laville M, Boissel JP</AU>
<TI>Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>2000</YR>
<VL>15</VL>
<NO>12</NO>
<PG>1986-92</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11096144"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fouque-2000b" MODIFIED="2008-10-14 11:03:48 +1100" MODIFIED_BY="[Empty name]" NAME="Fouque 2000b" TYPE="COCHRANE_REVIEW">
<AU>Fouque D, Wang PH, Laville M, Boissel JP</AU>
<TI>Low protein diets for chronic renal failure in non diabetic adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2008-10-14 11:03:46 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-10-14 11:03:46 +1100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001892"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fouque-2006" MODIFIED="2009-03-31 15:39:33 +1100" MODIFIED_BY="[Empty name]" NAME="Fouque 2006" TYPE="COCHRANE_REVIEW">
<AU>Fouque D, Laville M, Boissel J-P</AU>
<TI>Low protein diets for chronic kidney disease in non diabetic adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2009-03-31 15:39:30 +1100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-31 15:39:30 +1100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001892.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2009-04-21 08:57:01 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Meloni-2004" MODIFIED="2009-04-21 08:56:59 +1000" MODIFIED_BY="[Empty name]" NAME="Meloni 2004" TYPE="JOURNAL_ARTICLE">
<AU>Meloni C, Tatangelo P, Cipriani S, Rossi V, Suraci C, Tozzo C, et al</AU>
<TI>Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure</TI>
<SO>Journal of Renal Nutrition</SO>
<YR>2004</YR>
<VL>14</VL>
<NO>4</NO>
<PG>208-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Teplan-1998" MODIFIED="2009-04-21 08:57:01 +1000" MODIFIED_BY="[Empty name]" NAME="Teplan 1998" TYPE="JOURNAL_ARTICLE">
<AU>Teplan V, Schuck O, Bubenicek P, Mengerova O, Tesarova Z, Hajny J, et al</AU>
<TI>The effect of long-term administration of a low-protein diet on the metabolic status and progression of chronic renal failure: a multicentre study [abstract]</TI>
<SO>Nephrology Dialysis Transplantation</SO>
<YR>1998</YR>
<VL>13</VL>
<PG>820</PG>
<IDENTIFIERS/>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-04-21 09:01:07 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-04-21 09:00:53 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2009-04-21 08:59:15 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cianciaruso-2008">
<CHAR_METHODS MODIFIED="2009-03-31 15:42:42 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Randomisation method</B>: Computer generated<BR/>
<B>Blinding</B>: Yes<BR/>
<B>Intention-to-treat</B>: No<BR/>
<B>Country</B>: Italy<BR/>
<B>Setting</B>: University Hospital CKD clinic</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-31 16:09:04 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>Number: 392</LI>
<LI>Age: 61 ± 18 years</LI>
<LI>Gender (M/F): 220/172</LI>
<LI>eGFR &#8804; 30 mL/min/1.73 m²</LI>
<LI>Stable renal function</LI>
</UL>
<P>
<B>Treatment group</B>
</P>
<UL>
<LI>Number: 200</LI>
<LI>Age: 61 ± 16 years</LI>
<LI>Gender (M/F):112/88</LI>
</UL>
<P>
<B>Control group</B>
</P>
<UL>
<LI>Number: 192</LI>
<LI>Age: 62 ± 18 years</LI>
<LI>Gender (M/F): 110/82</LI>
</UL>
<P>
<B>Exclusion criteria</B>
</P>
<UL>
<LI>Malignant disease</LI>
<LI>Treatment with immunosuppressive drugs</LI>
<LI>UPE &gt; 5 g/24 h</LI>
<LI>Pregnancy</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-21 08:59:15 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group</B>
</P>
<UL>
<LI>0.55 g/kg/d</LI>
</UL>
<P>
<B>Control group</B>
</P>
<UL>
<LI>0.8 g/kg/d</LI>
</UL>
<P>
<B>Cointerventions</B>
</P>
<UL>
<LI>Patients were prescribed at least 30 kcal/kg/d (25 kcal/kg/d for overweight patients or if hypertension or hyperlipidaemia present)</LI>
<LI>Daily multivitamin and mineral tablet</LI>
<LI>Dietary sodium intake restricted to 2.5 g/d</LI>
<LI>Calcium supplements to guarantee calcium intake of 1000-1500 mg/d</LI>
<LI>Iron supplementation (200 mg/d oral element iron) as required to maintain transferrin saturation &#8805; 20%</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-26 11:11:24 +1100" MODIFIED_BY="Narelle S Willis">
<UL>
<LI>Urea nitrogen</LI>
<LI>Phosphate</LI>
<LI>PTH</LI>
<LI>Bicarbonate</LI>
<LI>Death</LI>
<LI>Commenced dialysis</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-04-21 09:00:53 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-di-Iorio-2003">
<CHAR_METHODS MODIFIED="2009-03-31 15:43:17 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Randomisation method</B>: NS<BR/>
<B>Blinding</B>: NS<BR/>
<B>Intention-to-treat</B>: NS<BR/>
<B>Setting</B>: Outpatient clinic, Italy</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-31 16:08:51 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>CrCl &#8804; 25 mL/min/1.73 m²</LI>
<LI>EPO for 6-12 months</LI>
</UL>
<P>
<B>Treatment group</B>
</P>
<UL>
<LI>Number: 10</LI>
<LI>Age: 57 ± 17 years</LI>
<LI>Gender (M/F): 6/4</LI>
</UL>
<P>
<B>Control group</B>
</P>
<UL>
<LI>Number: 10</LI>
<LI>Age: 52 ± 15 years</LI>
<LI>Gender M/F: 6/4</LI>
</UL>
<P>3 patients in each group had diabetic kidney disease</P>
<P>
<B>Exclusion criteria</B>
</P>
<UL>
<LI>Bleeding or diseases potentially affecting EPO response (i.e. neoplastic diseases, infectious diseases, severe malnutrition)</LI>
<LI>CKD stage: 4-5</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-31 15:54:43 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (VLP)</B>
</P>
<UL>
<LI>0.3 g protein/kg/d</LI>
</UL>
<P>
<B>Control group (LP)</B>
</P>
<UL>
<LI>0.6 g protein/kg/d</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-31 15:55:15 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>CrCl</LI>
<LI>MAP</LI>
<LI>Urinary sodium mEq/d</LI>
<LI>Triglycerides mg/dL</LI>
<LI>Cholesterol mg/dL</LI>
<LI>Renal death: End point: CrCl &#8804; 7 mL/min/1.73 m² or development of uraemic complications requiring haemodialysis</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-04-21 09:00:53 +1000" MODIFIED_BY="[Empty name]">
<UL>
<LI>3 month run-in period before randomisation to verify stability of Hb coefficient</LI>
<LI>Follow-up: 24 months</LI>
<LI>All patients required to restrict dietary sodium intake</LI>
<LI>Treatment group diet was supplemented with a mixture of ketoanalogues and essential amino acids (Alfa Kappa) 1 tablet/5 kg BW.</LI>
</UL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-31 16:00:33 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ihle-1989">
<CHAR_METHODS MODIFIED="2009-03-31 15:59:22 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Study type</B>: Prospective randomised<BR/>
<B>Duration</B>: 18 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-31 16:00:33 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>SCr 350-1000 µmol/L at enrolment</LI>
<LI>Gender ratio (M/F): 0.67</LI>
<LI>CKD stage: 4-5</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-31 16:00:04 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (LPD)</B>
</P>
<UL>
<LI>0.4 g protein/kg/d</LI>
</UL>
<P>
<B>Control group (free diet)</B>
</P>
<UL>
<LI>Greater than 0.75 g/kg/d</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-31 16:00:08 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Decline in GFR over time</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Data obtained from 72 included patients (not from data on 64 patients of the final report)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-31 16:08:41 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jungers-1987">
<CHAR_METHODS MODIFIED="2009-03-31 16:02:31 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Study type</B>: Prospective randomised<BR/>
<B>Duration</B>: 12 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-31 16:08:41 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>inclusion criteria</B>
</P>
<UL>
<LI>SCr 500 and 900 µmol/L at inclusion</LI>
<LI>Age: 62 (32-79) years</LI>
<LI>M/F ratio: 0.37</LI>
<LI>CKD stage: 5</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-31 16:02:49 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (LPD)</B>
</P>
<UL>
<LI>0.4 g protein/kg/d</LI>
<LI>Oral supplement with ketoacids (1 tab Ketosteril/kg BW/d)</LI>
</UL>
<P>
<B>Control group</B>
</P>
<UL>
<LI>0.6 g protein/kg//d</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-31 16:03:04 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Increase in SCr during study</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Small effective (n = 19)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-31 16:08:37 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Locatelli-1991">
<CHAR_METHODS MODIFIED="2009-03-31 16:04:41 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Study type</B>: Prospective randomised<BR/>
<B>Setting</B>: Multicentre<BR/>
<B>Duration</B>: 24 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-31 16:08:37 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>SCR 130 - 620 µmol/L at enrolment</LI>
<LI>Age: 49 (18-65) years</LI>
<LI>M/F ratio: 0.54</LI>
<LI>CKD stage: 3-4</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-31 16:06:14 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (LPD)</B>
</P>
<UL>
<LI>0.6 g protein/kg/d</LI>
</UL>
<P>
<B>Control group</B>
</P>
<UL>
<LI>1.0 g protein/kg/d</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-31 16:07:47 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Renal survival curve (including start of dialysis or a doubling of baseline SCr during study)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-31 16:08:01 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>True difference in protein intake less than 0.4 g protein/kg/d, estimated to be 0.16 g/kg/d based on urinary analysis and 0.3 g/kg/d based on diet records</LI>
<LI>Events recorded at 24 months from the start of study</LI>
</UL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-31 16:11:19 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Malvy-1999">
<CHAR_METHODS MODIFIED="2009-03-31 16:08:24 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Study type: </B>Prospective randomised<BR/>
<B>Duration</B> 18 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-31 16:10:29 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>SCr 300-900 µmol/L at enrolment</LI>
<LI>Age: 55 (15-75) years</LI>
<LI>M/F ratio: 0.58</LI>
<LI>CKD stage: 4-5</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-31 16:11:05 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (LPD)</B>
</P>
<UL>
<LI>0.3 g protein/kg/d</LI>
<LI>Oral ketoacid supplement (Ketosteril 1 tab/6 kg BW/d)</LI>
</UL>
<P>
<B>Control group</B>
</P>
<UL>
<LI>0.65 g protein/kg/d</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-31 16:11:19 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Dialysis or death on survival curve</LI>
<LI>Renal death (death or start of dialysis during study) observed at two years</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-31 16:22:34 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-MDRD-1994">
<CHAR_METHODS MODIFIED="2009-03-31 16:11:44 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Study type: </B>Prospective randomised<BR/>
<B>Setting: </B>Multicentre<BR/>
<B>Duration</B>: 23 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-31 16:22:34 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>Renal function</LI>
<UL>
<LI>Study 1: 25-55 mL/min/1.73 m²</LI>
<LI>Study 2: 13-24 mL/min/1.73m²</LI>
</UL>
<LI>MAP: &lt; 125 mm Hg</LI>
<LI>Age: 52 years</LI>
<LI>M/F ratio: 0.60</LI>
<LI>CKD stage</LI>
<UL>
<LI>Study 1: 3-4</LI>
<LI>Study 2: 4</LI>
</UL>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-31 16:21:49 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (study 1)</B>
</P>
<UL>
<LI>0.58 g protein/kg/d</LI>
</UL>
<P>
<B>Control group (study 1)</B>
</P>
<UL>
<LI>1.3 g protein /kg/d</LI>
</UL>
<P>
<B>Treatment group (study 2)</B>
</P>
<UL>
<LI>0.28 g protein/kg/d</LI>
<LI>Oral ketoacid supplement</LI>
</UL>
<P>
<B>Control group (study 2)</B>
</P>
<UL>
<LI>0.58 g protein/kg/d</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-31 16:16:31 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Slope of GFR decline over time during 2.2 years</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-31 16:22:01 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Data were obtained only for study 1</LI>
<LI>Event number differs from publication since the publication included events observed during follow-up.</LI>
</UL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-04-21 09:00:34 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mirescu-2007">
<CHAR_METHODS MODIFIED="2009-03-31 16:22:21 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Country</B>: Romania<BR/>
<B>Setting</B>: Single centre, prospective, open label, parrallel RCT<BR/>
<B>Duration</B>: 60 weeks with a 12-week baseline phase<BR/>
<B>Time frame</B>: 15 Jan 2004 to 15 Feb 2005</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-04-08 09:58:19 +1000" MODIFIED_BY="Narelle S Willis">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>Adults</LI>
<LI>eGFR &lt; 0.5 mL/s (30 mL/min/1.73 m², MDRD formula)</LI>
<LI>Stable renal function for at least 12 weeks before enrollment (reduction in eGFR &#8804; 4 mL/min/y)</LI>
<LI>Well controlled arterial pressure</LI>
<LI>Proteinuria &lt; 1 g/g urinary Cr</LI>
<LI>Good nutritional status (subjective Global Assessment score A/B; serum albumin &gt; 35 g/L)</LI>
<LI>Anticipated good compliance with the prescribed diet</LI>
</UL>
<P>
<B>Treatment group</B>
</P>
<UL>
<LI>Number: 27</LI>
<LI>Age: 55 ± 12.7 years</LI>
<LI>Gender (males): 63%</LI>
</UL>
<P>
<B>Control group</B>
</P>
<UL>
<LI>Number: 26</LI>
<LI>Age: 53.6 ± 11.0 years</LI>
<LI>Gender (males): 58%</LI>
</UL>
<P>
<B>Exclusion criteria</B>
</P>
<UL>
<LI>Poorly controlled arterial pressure (&gt; 145/85 mm Hg)</LI>
<LI>Comorbid conditions: Diabetes mellitus, heart failure, active hepatic disease, digestive diseases with malabsorption, inflammation/anti-inflammatory therapy</LI>
<LI>Uremic complications: Pericarditis, polyneuropathy</LI>
<LI>Feeding inability: Anorexia, nausea</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-04-21 09:00:34 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group</B>
</P>
<UL>
<LI>Severe hypoproteic diet supplemented with ketoanalogues</LI>
<UL>
<LI>0.3 g/kg/d vegetable protein</LI>
</UL>
<LI>Ketoanalogues or essential amino acids (Ketosteril, Fresnius Kabi, Bad Homburg, Germany)</LI>
<UL>
<LI>1 capsule/5 kg of ideal body weight/d</LI>
</UL>
<LI>Total recommended energy intake: 30 kcal/kg/d</LI>
</UL>
<P>
<B>Control group</B>
</P>
<UL>
<LI>Conventional low protein diet</LI>
<UL>
<LI>0.6 g/kg/d (including high biological value proteins)</LI>
</UL>
<LI>Total recommended energy intake: 30 kcal/kg/d</LI>
</UL>
<P>
<B>Co-interventions</B>
</P>
<UL>
<LI>All received calcium and water soluble vitamin supplementation as required.</LI>
<LI>Serum ferritin</LI>
<UL>
<LI>&lt; 200 ng/mL: 100 mg IV iron sucrose weekly.</LI>
<LI>200-400 ng/mL: 100 mg IV iron sucrose every other week</LI>
<LI>400-500 ng/mL: 100 mg IV iron sucrose monthly</LI>
<LI>&gt; 500 ng/mL: Iron administration stopped</LI>
</UL>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-11-26 09:39:07 +1100" MODIFIED_BY="Narelle S Willis">
<UL>
<LI>Nitrogen waste products: serum urea and Cr</LI>
<LI>Calcium-phosphorus metabolism: serum calcium, serum phosphate, calcium-phosphorous product, alkaline phosphatase activity</LI>
<LI>Acid-base balance: serum bicarbonate</LI>
<LI>Death: patient or 'kidney'</LI>
<LI>Blood pressure</LI>
<LI>Drug therapy requirements for hypertension</LI>
<LI>Adverse events</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-11-26 11:06:07 +1100" MODIFIED_BY="Narelle S Willis">
<UL>
<LI>Dietary compliance was assessed weekly for the first month, every 4 weeks for the next 8 weeks and every 12 weeks thereafter</LI>
</UL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-31 16:33:00 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rosman-1989">
<CHAR_METHODS MODIFIED="2009-03-31 16:26:07 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Study type: </B>Prospective randomised<BR/>
<B>Duration</B>: 18 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-31 16:27:59 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>CrCl</LI>
<UL>
<LI>10-30 mL/min (groups A2 and C)</LI>
<LI>30-60 mL/min (groups A1and B)</LI>
</UL>
<LI>Age: 48 (15-73) years</LI>
<LI>M/F ratio: 0.54</LI>
<LI>CKD stage</LI>
<UL>
<LI>group A1: 3</LI>
<LI>A2: 4-5</LI>
<LI>B: 3</LI>
<LI>C: 4-5</LI>
</UL>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-31 16:33:00 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment groups</B>
</P>
<UL>
<LI>0.6 g protein/kg/d (group B)</LI>
<LI>0.4 g protein/kg/d (group C)</LI>
</UL>
<P>
<B>Control groups</B>
</P>
<UL>
<LI>Free diet (groups A1 and A2)</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-31 16:29:10 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Slope of reciprocal SCr (1/SCr) over time</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-31 16:29:21 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Updated report (1989) from previous paper (Lancet 1984; ii:1291-1296)</LI>
<LI>Eight patients received a renal transplant in the LPD group and four in the control group and were counted as renal death event</LI>
</UL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-03-31 16:32:32 +1100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Williams-1991">
<CHAR_METHODS MODIFIED="2009-03-31 16:30:16 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Study type: </B>Prospective randomised<BR/>
<B>Duration</B>: 18 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-03-31 16:32:32 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>SCr: 200-600 µmol/L at enrolment</LI>
<LI>Age: 44 (15-70) years</LI>
<LI>M/F ratio: 0.63</LI>
<LI>CKD stage: 4-5</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-03-31 16:31:58 +1100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group</B>
</P>
<UL>
<LI>0.6 g protein/kg/d</LI>
</UL>
<P>
<B>Control group</B>
</P>
<UL>
<LI>&gt; 0.8 g protein/kg/d</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-03-31 16:32:10 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Slope of reciprocal SCr (1/SCr) over time</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-03-31 16:32:19 +1100" MODIFIED_BY="[Empty name]">
<UL>
<LI>A third group of patients (low phosphorus intake, n = 30) was not kept for analysis</LI>
<LI>Events recorded at 18 months from the start of study</LI>
</UL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>CKD - chronic kidney disease; CrCl - creatinine clearance; eGFR - estimated glomerular filtration rate; LPD - low protein diet; MAP - mean arterial pressure mm Hg; NS - not stated; SCr - serum creatinine; UPE - urinary protein excretion<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-04-21 09:01:07 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Alvestrand-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Alvestrand-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Attman-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Attman-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Barsotti-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Barsotti-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Barsotti-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 13:50:03 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Bellizzi-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 13:50:02 +1100" MODIFIED_BY="Narelle S Willis">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bennett-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 15:04:50 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Bergstrom-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 15:04:50 +1100" MODIFIED_BY="Narelle S Willis">
<P>RCT. Not the final report - 57 patients randomised but data on only 16 patients presented. Renal death not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-04-21 09:01:07 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bernhard-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-04-21 09:01:07 +1000" MODIFIED_BY="[Empty name]">
<P>RCT - randomised to ketoanalogue supplements not protein diet</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Brunori-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>No controlled protein intake</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Burns-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 13:57:37 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Coresh-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 13:57:37 +1100" MODIFIED_BY="Narelle S Willis">
<P>RCT - randomised to keto acid supplements</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-D_x0027_Amico-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>A number of patients included have been published in the larger Locatelli's study (Lancet 1991) kept for the meta-analysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dek-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Di-Landro-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 13:55:28 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-DODE-Study-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 13:55:28 +1100" MODIFIED_BY="Narelle S Willis">
<P>RCT - randomised to diet or dialysis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-El-Nahas-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Esaian-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Frohling-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Frohling-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Frohling-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 14:01:00 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Fuessl-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 14:01:00 +1100" MODIFIED_BY="Narelle S Willis">
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gretz-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hecking-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Six weeks duration only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 13:59:51 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-IRCCA-Study-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 13:59:51 +1100" MODIFIED_BY="Narelle S Willis">
<P>RCT - randomised to keto acid supplements</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 14:04:12 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Ivarsen-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 14:04:12 +1100" MODIFIED_BY="Narelle S Willis">
<P>RCT - haemodialysis patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kampf-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Levine-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lim-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Six months duration only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lucas-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-04-08 10:24:20 +1000" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Maksic-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-04-08 10:24:20 +1000" MODIFIED_BY="Narelle S Willis">
<P>RCT - six months duration</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 14:06:50 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Maroni-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 14:06:50 +1100" MODIFIED_BY="Narelle S Willis">
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Maschio-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Masud-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Metabolic study, no relevant outcomes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Meisinger-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mitch-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 14:10:00 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Moreira-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 14:10:00 +1100" MODIFIED_BY="Narelle S Willis">
<P>RCT - haemodialysis patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Oldrizzi-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Patel-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Prakash-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Less than 12 months duration</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-04-08 09:59:28 +1000" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Riabov-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-04-08 09:59:28 +1000" MODIFIED_BY="Narelle S Willis">
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 14:13:24 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Sanfelippo-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 14:13:24 +1100" MODIFIED_BY="Narelle S Willis">
<P>RCT - haemodialysis patients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schmicker-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Teplan-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention is EPO not protein</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 14:21:10 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Teplan-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 14:21:10 +1100" MODIFIED_BY="Narelle S Willis">
<P>RCT - randomised to keto acids and placebo</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Terzi-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study performed in children</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Walser-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Walser-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not controlled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wingen-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Paediatric study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-26 14:24:37 +1100" MODIFIED_BY="Narelle S Willis" STUDY_ID="STD-Younes-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-26 14:24:37 +1100" MODIFIED_BY="Narelle S Willis">
<P>RCT - randomised to fermentable carbohydrate supplementation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zakar-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Zeller-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Diabetic patients only</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-04-08 09:58:04 +1000" MODIFIED_BY="Narelle S Willis">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-04-08 09:58:04 +1000" MODIFIED_BY="Narelle S Willis" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-04-08 09:58:04 +1000" MODIFIED_BY="Narelle S Willis" RESULT="YES" STUDY_ID="STD-Cianciaruso-2008">
<DESCRIPTION>
<P>Numbered opaque sealed envelopes opened in sequence by administration staff personnel not involved in patient care.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ihle-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jungers-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Locatelli-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-MDRD-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Malvy-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-26 10:00:25 +1100" MODIFIED_BY="Narelle S Willis" RESULT="UNKNOWN" STUDY_ID="STD-Mirescu-2007">
<DESCRIPTION>
<P>Not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rosman-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Williams-1991">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-di-Iorio-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2009-04-21 08:39:45 +1000" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-11-26 10:46:49 +1100" MODIFIED_BY="Narelle S Willis">
<COMPARISON ID="CMP-001" MODIFIED="2008-11-26 10:46:49 +1100" MODIFIED_BY="Narelle S Willis" NO="1">
<NAME>Low protein versus higher protein diets</NAME>
<DICH_OUTCOME CHI2="8.204556364327791" CI_END="0.835156851665185" CI_START="0.5533398113945595" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6797981573859166" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="168" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.07823195156377427" LOG_CI_START="-0.2570080822763987" LOG_EFFECT_SIZE="-0.16762001692008652" METHOD="MH" MODIFIED="2008-11-26 10:46:49 +1100" MODIFIED_BY="Narelle S Willis" NO="1" P_CHI2="0.5136708795362601" P_Q="0.0" P_Z="2.375571827417733E-4" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1002" TOTAL_2="998" WEIGHT="100.0" Z="3.6753138681523625">
<NAME>Renal death</NAME>
<GROUP_LABEL_1>Low protein</GROUP_LABEL_1>
<GROUP_LABEL_2>Higher protein</GROUP_LABEL_2>
<GRAPH_LABEL_1>Less deaths on low</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Less deaths on high</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.3742991666123268" CI_END="1.0537447161504911" CI_START="0.5419983505486538" DF="2.0" EFFECT_SIZE="0.755730043105953" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="70" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.022735409931789748" LOG_CI_START="-0.26600203513819587" LOG_EFFECT_SIZE="-0.12163331260320302" MODIFIED="2008-11-24 15:47:56 +1100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5030078602391925" P_Z="0.09867614410279164" STUDIES="3" TAU2="0.0" TOTAL_1="554" TOTAL_2="562" WEIGHT="38.33653424109657" Z="1.6513058219019425">
<NAME>0.6 g/kg/d versus higher protein diet</NAME>
<DICH_DATA CI_END="1.1321827193307548" CI_START="0.40048886422598273" EFFECT_SIZE="0.6733695652173913" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="32" LOG_CI_END="0.05391652189942229" LOG_CI_START="-0.39740955516636833" LOG_EFFECT_SIZE="-0.17174651663347298" ORDER="11536" O_E="0.0" SE="0.26511117176855803" STUDY_ID="STD-Locatelli-1991" TOTAL_1="230" TOTAL_2="236" VAR="0.07028393339649787" WEIGHT="15.69055164009323"/>
<DICH_DATA CI_END="1.1957166431560255" CI_START="0.3794004926811998" EFFECT_SIZE="0.6735395189003437" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="27" LOG_CI_END="0.07762827422279148" LOG_CI_START="-0.42090210948165385" LOG_EFFECT_SIZE="-0.1716369176294312" ORDER="11537" O_E="0.0" SE="0.29283921515319017" STUDY_ID="STD-MDRD-1994" TOTAL_1="291" TOTAL_2="294" VAR="0.08575480593153641" WEIGHT="12.8598470306965"/>
<DICH_DATA CI_END="2.0425208407411457" CI_START="0.5478765371442064" EFFECT_SIZE="1.0578512396694215" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.31016649652523764" LOG_CI_START="-0.26131729786240104" LOG_EFFECT_SIZE="0.024424599331418297" ORDER="11538" O_E="0.0" SE="0.33569240971370495" STUDY_ID="STD-Williams-1991" TOTAL_1="33" TOTAL_2="32" VAR="0.11268939393939395" WEIGHT="9.786135570306838"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.27362452200329" CI_END="0.8279862460170628" CI_START="0.4791836287799898" DF="6.0" EFFECT_SIZE="0.6298868580518072" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="98" I2="4.361506192211781" ID="CMP-001.01.02" LOG_CI_END="-0.0819768773799818" LOG_CI_START="-0.3194980279559024" LOG_EFFECT_SIZE="-0.2007374526679421" MODIFIED="2008-11-24 15:59:15 +1100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3932471224523335" P_Z="9.234436274391492E-4" STUDIES="7" TAU2="0.0065105876355253155" TOTAL_1="448" TOTAL_2="436" WEIGHT="61.663465758903435" Z="3.312868572954499">
<NAME>0.3 - 0.6 g/kg/d versus higher/free protein diets</NAME>
<DICH_DATA CI_END="1.5774316207183432" CI_START="0.30098230283691046" EFFECT_SIZE="0.6890420899854862" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" LOG_CI_END="0.19795054231341738" LOG_CI_START="-0.5214590393105587" LOG_EFFECT_SIZE="-0.16175424849857065" MODIFIED="2008-11-24 15:59:15 +1100" MODIFIED_BY="[Empty name]" ORDER="11" O_E="0.0" SE="0.42258474938078583" STUDY_ID="STD-Cianciaruso-2008" TOTAL_1="212" TOTAL_2="211" VAR="0.17857787040922157" WEIGHT="6.1754218700195445"/>
<DICH_DATA CI_END="1.052895839476776" CI_START="0.07753155630455415" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.02238540957299151" LOG_CI_START="-1.110521498273543" LOG_EFFECT_SIZE="-0.5440680443502757" ORDER="11539" O_E="0.0" SE="0.6654751256486924" STUDY_ID="STD-di-Iorio-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.44285714285714284" WEIGHT="2.4901792919310846"/>
<DICH_DATA CI_END="0.9543259841008704" CI_START="0.12392127934425351" EFFECT_SIZE="0.3438914027149321" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.020303251172455558" LOG_CI_START="-0.9068541116361832" LOG_EFFECT_SIZE="-0.46357868140431935" ORDER="11540" O_E="0.0" SE="0.5207643639339297" STUDY_ID="STD-Ihle-1989" TOTAL_1="34" TOTAL_2="38" VAR="0.27119552274351033" WEIGHT="4.066415533967413"/>
<DICH_DATA CI_END="1.3094041214253411" CI_START="0.3156132620635045" EFFECT_SIZE="0.6428571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.11707370355517462" LOG_CI_START="-0.5008447560330008" LOG_EFFECT_SIZE="-0.1918855262389131" ORDER="11541" O_E="0.0" SE="0.3629683619078001" STUDY_ID="STD-Jungers-1987" TOTAL_1="10" TOTAL_2="9" VAR="0.13174603174603175" WEIGHT="8.370602680105693"/>
<DICH_DATA CI_END="1.0857254047276859" CI_START="0.3856270833160418" EFFECT_SIZE="0.6470588235294118" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="17" LOG_CI_END="0.03571999993891077" LOG_CI_START="-0.41383247237900844" LOG_EFFECT_SIZE="-0.18905623622004886" ORDER="11542" O_E="0.0" SE="0.26406934756017325" STUDY_ID="STD-Malvy-1999" TOTAL_1="25" TOTAL_2="25" VAR="0.06973262032085559" WEIGHT="15.814602711792835"/>
<DICH_DATA CI_END="1.0421105532207489" CI_START="0.018159726092762014" EFFECT_SIZE="0.13756613756613756" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.017913793922148046" LOG_CI_START="-1.7408907063270003" LOG_EFFECT_SIZE="-0.8614884562024262" ORDER="12" O_E="0.0" SE="1.0331304696690382" STUDY_ID="STD-Mirescu-2007" TOTAL_1="27" TOTAL_2="26" VAR="1.0673585673585673" WEIGHT="1.0331988894376407"/>
<DICH_DATA CI_END="1.2118480149377224" CI_START="0.5203811283237941" EFFECT_SIZE="0.7941176470588235" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="34" LOG_CI_END="0.08344815579328274" LOG_CI_START="-0.2836784615598184" LOG_EFFECT_SIZE="-0.10011515288326783" ORDER="11543" O_E="0.0" SE="0.21565199233927668" STUDY_ID="STD-Rosman-1989" TOTAL_1="130" TOTAL_2="117" VAR="0.04650578179989945" WEIGHT="23.713044781649224"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-11-26 11:04:07 +1100" MODIFIED_BY="Narelle S Willis">
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-11-26 11:04:07 +1100" MODIFIED_BY="Narelle S Willis" NO="1" REF_ID="CMP-001.01" SETTINGS="SHOW_STUDY_NAMES:NO;SHOW_CI_LINES:YES;SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Low protein versus higher protein diets, outcome: 1.1 Renal death.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2009-04-21 08:44:11 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2009-04-21 08:44:11 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-04-21 08:39:31 +1000" MODIFIED_BY="[Empty name]">Electronic search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2009-04-21 08:44:11 +1000" MODIFIED_BY="[Empty name]">
<TABLE COLS="2" ROWS="3">
<TR>
<TH VALIGN="TOP">
<P>Database</P>
</TH>
<TH VALIGN="TOP">
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>MEDLINE</P>
</TD>
<TD VALIGN="TOP">
<OL>
<LI>Randomized Clinical Trial.pt</LI>
<LI>Controlled Clinical Trial.pt</LI>
<LI>Clinical Trial.pt</LI>
<LI>Random</LI>
<LI>Double blind method</LI>
<LI>Single blind method</LI>
<LI>Placebo</LI>
<LI>OR 1-7</LI>
<LI>Animal not Human</LI>
<LI>8 not 9</LI>
<LI>Kidney disease OR Kidney failure</LI>
<LI>Nephropathy</LI>
<LI>Chronic renal disease</LI>
<LI>OR 11-13</LI>
<LI>10 AND 14</LI>
<LI>Dietary intervention OR nutritional intervention</LI>
<LI>Diet protein restricted</LI>
<LI>16 OR 17</LI>
<LI>15 AND 18</LI>
<LI>Adults NOT children</LI>
<LI>19 AND 20</LI>
<LI>Not Diabetic</LI>
</OL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>CENTRAL</P>
</TD>
<TD VALIGN="TOP">
<OL>
<LI>KIDNEY FAILURE</LI>
<LI>KIDNEY FAILURE CHRONIC</LI>
<LI>(end-stage next renal next failure)</LI>
<LI>(end-stage next kidney next failure)</LI>
<LI>(end next stage next renal next failure)</LI>
<LI>(end next stage next kidney next failure)</LI>
<LI>(end next stage next renal next disease)</LI>
<LI>(end next stage next kidney next disease)</LI>
<LI>(end-stage next renal next disease)</LI>
<LI>(end-stage next kidney next disease)</LI>
<LI>(chronic next renal next failure)</LI>
<LI>(chronic next renal next disease)</LI>
<LI>(chronic next kidney next disease)</LI>
<LI>(chronic next kidney next failure)</LI>
<LI>(#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14)</LI>
<LI>DIET PROTEIN-RESTRICTED</LI>
<LI>DIET THERAPY</LI>
<LI>(low-protein next diet*)</LI>
<LI>(low next protein next diet*)</LI>
<LI>(protein next restrict*)</LI>
<LI>(protein next reduct*)</LI>
<LI>(diet* next restrict*)</LI>
<LI>(diet* next intervention*)</LI>
<LI>(nutrition* next intervention*)</LI>
<LI>(#16 or #17 or #18 or #19 or #20 or #21 or #22 or #24)</LI>
<LI>(#15 and #25)</LI>
</OL>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>